Saturday, June 18 Breakfast Workshop Red Hall 1 ... · G.A. van Montfrans (Amsterdam, The Netherlands) Deep relaxation needed for shallow drop in blood pressure. Overview of clinical

61Fifteenth European Meeting on Hypertension Milan, Italy, June 17/21, 2005

07.15-08.15 Hypertension, metabolic syndrome andPPARs

Chairman:T. Unger (Berlin, Germany)

PPARα and hypertensive cardiomyopathyJ. Diez (Pamplona, Spain)

PPARγ - A new drug target for high-riskhypertensive patientsU. Kintscher (Berlin, Germany)

Saturday, June 18 Red Hall 1

Breakfast Workshop

62 Fifteenth European Meeting on Hypertension Milan, Italy, June 17/21, 2005

07.15-08.15 Spectral analysis in hypertension

Chairman:M. Pagani (Milan, Italy)

Spectral analysis in hypertension: a bio-engineer perspectiveM. Di Rienzo (Milan, Italy)

Spectral analysis as a tool for autonomicassessmentP. Sleight (Oxford, UK)


Breakfast Workshop


07.15-08.15 Clinical value of exercise blood pressure

Chairman:S.E. Kjeldsen (Oslo, Norway)

Clinical value of exercise blood pressure inapparently healthy middle-aged subjects fromthe general populationE. Fossum (Oslo, Norway)

Clinical value of exercise blood pressure inhypertension and heart failure. The “unifyinghypothesis”R. Fagard (Leuven, Belgium)

Saturday, June 18 Blue Hall

Breakfast Workshop


07.15-08.15 Lowering blood pressure throughpsychobehavioural manoeuvres

Chairman:G.A. van Montfrans (Amsterdam, The Netherlands)

Deep relaxation needed for shallow drop inblood pressure. Overview of clinical trialsG.A. van Montfrans (Amsterdam, The Netherlands)

Effects on blood pressure of TranscendentalMeditation, a critical appraisal for theuninitiatedB.J. van den Born (Amsterdam, The Netherlands)

Saturday, June 18 Yellow Hall

Breakfast Workshop


Chairmen: A. Januszewicz (Warsaw, Poland)G. London (Fleury-Mérogis, France)

8.30 • HCaRG INCREASES RENAL CELL MIGRATION BY AN INTERNAL TGF-ALPHAAUTOCRINE LOOP MECHANISMC. El Hader, S. Tremblay, P. Hamet, J. Tremblay (Montreal, Canada)

8.45 • SYMPATHETIC HYPERACTIVITY IN HYPERTENSIVE CHRONIC KIDNEYDISEASE PATIENTS IS NOT FULLY EXPLAINED BY THE ACTIVATED RENIN-ANGIOTENSIN SYSTEMJ. Neumann, G. Ligtenberg, I.H.H.T. Klein, P. Boer, H.A. Koomans, P.J. Blankestijn(Utrecht, The Netherlands)

9.00 • THE SECRET STUDY - STUDY ON EVALUATION OF CANDESARTANCILEXETIL AFTER RENAL TRANSPLANTATIONC. Legendre, T. Philipp*, R.E. Schmieder**, G. Mourad***, H. Geiger****, B. Moulin°, S. Nisse-Durgeat°°, G. Kiel°°° (Paris, France; *Essen, **Erlangen,Germany; ***Montpellier, France; ****Frankfurt a. M., Germany; °Strasbourg,°°Puteaux, France; °°°Aachen, Germany)

9.15 • INFLUENCE OF BLOOD PRESSURE AND ANTIHYPERTENSIVE TREATMENTON GRAFT SURVIVAL AFTER KIDNEY TRANSPLANTATIONM. Hausberg, K. Loley, A. Levers, D. Lang, K. Kisters*, M. Barenbrock** (Muenster,*Herne, **Hamm, Germany)

9.30 • COCKRFOT-GAULT FORMULA IMPROVES SERUM CREATININECORRELATION WITH TARGET ORGAN DAMAGE IN ESSENTIAL HYPERTENSIONC. Campo, J. Segura, C. Roldan, L. Fernandez, L. Guerrero, L. Vigil, L.M. Ruilope(Madrid, Spain)

9.45 • ELEVATED PULSE PRESSURE IS ASSOCIATED WITH INAPPROPRIATELYLOW RENAL FUNCTION IN ELDERLY PATIENTS WITH ISOLATED SYSTOLICHYPERTENSIONJ. Verhave, P. Fesler, G. du Cailar, J. Ribstein, M. Safar*, A. Mimran (Montpellier,*Paris, France)

10.00 • LECTURE:“CHRONIC KIDNEY DISEASE AS CARDIOVASCULAR RISK FACTOR”J.L. Rodicio (Madrid, Spain)

Saturday, June 18 Red Hall 18.30-10.30

Renal AspectsOral Session 1A


Chairmen:J.L. Reid (Glasgow, UK)P. van de Borne (Bruxelles, Belgium)

8.30 • PATHOGENETIC MECHANISMS IN THE DEVELOPMENT OF THE METABOLICSYNDROME AND ITS COMPLICATIONS: ROLE OF SYMPATHETIC ACTIVITYD. Longo, D. Perkovic, V. Zaetta, E. Bonso, R. Garbelotto, P. Frezza, M. Winnicki, P. Palatini (Padua, Italy)

8.45 • ARE AUTONOMIC AND HEMODYNAMIC RESPONSES TO ALCOHOL GENDER-DEPENDENT?D. Hering, V.K. Somers*, T. Kara*, W. Kucharska, P. Jurak*, L. Bieniaszewski,K. Narkiewicz (Gdansk, Poland; *Rochester, MN, USA)

9.00 • POLYUNSATURATED FATTY ACIDS AND NEURAL CARDIOVASCULARCONTROLA. Radaelli, M. Centola*, A. Viola*, M. Cazzaniga*, M.G. Signorini**, A. Azzellino**,A.U. Ferrari** (Seregno-MI, *Monza-MI, **Milan, Italy)

9.15 • DIABETIC NEUROPATHY IS A MORE IMPORTANT DETERMINANT OFBAROREFLEX SENSITIVITY THAN CAROTID ARTERY ELASTICITY IN PATIENTSWITH TYPE 2 DIABETESD. Hayoz, S. Perret, J. Ruiz, D. Monbaron, E. Haesler, C. Danzeisen, G. Parati*(Lausanne, Switzerland; *Milan, Italy)

9.30 • SLOW BREATHING IMPROVES BLOOD OXYGEN SATURATION IN SUBJECTSEXPOSED TO HIGH ALTITUDE RELATED HYPOXIAG. Parati, G. Bilo, G. Caldara, A. Giglio, I. Riva, K. Styczkiewicz, D. Susta, G. Savia*, G. Branzi, A. Maronati, P. Modesti**, G. Mancia (Milan, *Piancavallo-VB, **Florence,Italy)

9.45 • EVIDENCE AGAINST A MAJOR ROLE OF ANGIOTENSIN II FORNORADRENALINE RELEASE AND LEFT VENTRICULAR HYPERTROPHY IN THEHYPERTENSIVE HUMAN HEARTM. Schlaich, D. Kaye*, E. Lambert*, D. Campbell*, J. Hastings*, G. Lambert*, M. Esler* (Erlangen, Germany; *Melbourne, Australia)

10.00 • RESPONSE TO ACUTE ELECTRICAL ACTIVATION OF THE CAROTIDBAROREFLEX IS MAINTAINED IN DRUG REFRACTORY HYPERTENSIONJ. Schmidli, M. Mohaupt, H. Savolainen, Y. Allemann, E. Irwin*, T. Peters**, R. Martin**, R. Kieval**, T. Carrel (Bern, Switzerland; *Robbinsdale, MN,**Minneapolis, MN, USA)

10.15 • ACROMEGALY IS ASSOCIATED WITH NORMAL SYMPATHETIC OUTFLOWY.B. Sverrisdottir, M. Elam, G. Johannsson (Göteborg, Sweden)


Autonomic Nervous SystemOral Session 1B


Chairmen:R.H. Fagard (Leuven, Belgium)M. Safar (Paris, France)

8.30 • CIRCULATING ENDOTHELIAL PROGENITOR CELLS, C-REACTIVE PROTEINAND SEVERITY OF CORONARY STENOSIS IN CHINESE PATIENTS WITHCORONARY ARTERY DISEASEP. Gao, H. Wang, D. Zhu (Shanghai, China)

8.45 • DIVERGENT ROLES OF AT1 AND AT2 RECEPTORS IN MYOCARDIALISCHEMIA-INDUCED APOPTOSIS AND INFLAMMATIONJ. Li, E. Kaschina, K. Elkhrbash, M. Timm, M. Sommerfeld, T. Unger (Berlin, Germany)

9.00 • PULSE PRESSURE IS ASSOCIATED WITH LEFT ATRIAL SIZE INHYPERTENSIVE PATIENTSP. Lantelme, S. Laurent*, C. Mouly, M. Vincent, H. Milon (Lyon, *Paris, France)

9.15 • PREVALENCE AND CORRELATES OF LEFT ATRIAL ENLARGEMENT INESSENTIAL HYPERTENSION: ROLE OF VENTRICULAR GEOMETRY AND THEMETABOLIC SYNDROMEE. Catini, C. Cuspidi, S. Meani, V. Fusi, C. Valerio, C. Sala, F. Magrini, A. Zanchetti(Milan, Italy)

9.30 • INAPPROPRIATE LEFT VENTRICULAR MASS IDENTIFIES HYPERTENSIVEPATIENTS WITH A CARDIAC PHENOTYPE PREDISPOSING TO HEART FAILUREM. Chinali, C. Romano, G. D’Addeo, M. Benincasa, M. De Marco, M. Galderisi, G. de Simone (Naples, Italy)

9.45 • ARTERIAL DISTENSIBILITY IN DIASTOLIC HEART FAILUREC. Giannattasio, A. Capra, D. Corsi, E. Fantini, S. Maestroni, M. Alloni, A. Cafro, M. Failla, A. Vincenzi, A. Cirò, A. Grieco, G. Mancia (Milan, Italy)

10.00 • ISOPROTERENOL INDUCED CARDIAC HYPERTROPHY IS ASSOCIATEDWITH VASCULAR DYSFUNCTION AND VASCULAR INFLAMMATIONA.C.P. Davel, D. Sanz-Rosa*, B. Martin*, M. Miana*, E. Cediel*, N. De las Heras*, V. Cachofeiro*, L.V. Rossoni, V. Lahera* (Sao Paulo, Brazil; *Madrid, Spain)

10.15 • DOES ACUTE VOLUME DEPLETION INFLUENCE THE ASSESSMENT OFLEFT VENTRICULAR STRUCTURE, FUNCTION AND VASCULAR COMPLIANCETh.K. Schwarz, J. Schwab, T. Schäufele, M.G. Gottwik, I. Bär, R.E. Schmieder(Nürnberg, Germany)

Saturday, June 18 Yellow Hall8.30-10.30

HeartOral Session 1C


Chairmen:P. Aranda (Malaga, Spain)L.H. Lindholm (Umea, Sweden)

8.30 • MICROALBUMINURIA, CARDIOVASCULAR RISK FACTORS AND BLOODPRESSURE SEVERITYA. De la Sierra, M.I. Egocheaga*, C. Fernandez-Lavandera*, M.T. Antonio,M.T. Aguilera, J.M. Taboada (Barcelona, *Madrid, Spain)

8.45 • INCREASE IN AMBULATORY PP DURING A 10-YEAR PERIOD WASSIGNIFICANTLY HIGHER IN WHITE COAT HYPERTENSIVES COMPARED TONORMOTENSIVES AND ESTABLISHED HYPERTENSIVESP.H. Gustavsen, A. Hoegholm, L.A. Bang*, K.S. Kristensen** (Naestved,*Copenhagen, **Holbaek, Denmark)

9.00 • HIGH PULSE PRESSURE AS A MARKER OF PRECLINICALCARDIOVASCULAR DISEASEG. de Simone, M.J. Roman*, M.H. Alderman*, M. Galderisi, O. de Divitiis, R.B. Devereux*(Naples, Italy; *New York, NY, USA)

9.15 • THE INCIDENCE OF ABNORMAL EXERCISE BLOOD PRESSURE RESPONSE,LEFT VENTRICULAR HYPERTROPHY AND DIASTOLIC DYSFUNCTION IS HIGHER INPRE AND HYPERTENSIVE MENA.E. Pittaras, P.F. Kokkinos*, P. Narayan*, G.D. Kolovou, V. Papademetriou*, S. Singh*, A.J. Manolis (Athens, Greece; *Washington, DC, USA)

9.30 • HIGH NORMAL BLOOD PRESSURE: NO SIGNIFICANT CARDIOVASCULAREXCESS RISK IN YOUNGER MEN?H. Milon, P. Champomier, P. Lantelme, M.O. Rial, C. Mouly-Bertin, K. Stankovic, F. Delahaye (Lyon, France)

9.45 • RENAL FUNCTION AND ITS EVOLUTION AS PREDICTORS OFCARDIOVASCULAR RISK IN PATIENTS WITH STABLE ANGINA. DATA FROM THEACTION STUDYL.M. Ruilope, B.A. Kirwan, G. Wagener, J. Segura, J. Soler-Soler, J. Lubsen, P.A. Poole-Wilson, on behalf of the ACTION Study Investigators (Madrid, Spain)

10.00 • COMPARISONS OF PREDICTIVE VALUE FOR THE CHINESE POPULATIONBETWEEN THE FRAMINGHAM CHD RISK ASSESSMENT TOOL AND THE FUNCTIONDERIVED FROM A CHINESE COHORT STUDYZ. Wu, J. Liu, D. Zhao, W. Wang (Beijing, China)

10.15 • RELATION BETWEEN BRACHIAL-ANKLE PULSE WAVE VELOCITY ANDFRAMINGHAM RISK SCOREE.J. Kim, H.G. Song, J.Y. Yu, W.S. Cheon, S.W. Han, Y.J. Choi, K.H. Ryu, C.Y. Rhim(Anyang, Republic of Korea)

Saturday, June 18 Blue Hall8.30-10.30

Cardiovascular RiskOral Session 1D


11.00-12.30 Hypertension in Children

Chairmen:E. Lurbe (Valencia, Spain)G. Parati (Milan, Italy)

Prevalence of overweight and obesity inEuropeT. Seeman (Prague, Czech Republic)

Obesity and hypertensionE. Lurbe (Valencia, Spain)

Obesity and metabolic syndromeC. Invitti (Milan, Italy)

Discussion

Saturday, June 18 Auditorium

Topical Workshop


Chairmen:R.E. Schmieder (Erlangen, Germany)A. Stella (Milan, Italy)

11.00 • RAPID NON-GENOMIC NEGATIVE INOTROPIC EFFECTS OF ALDOSTERONEIN THE HUMAN HEARTW. Chai, A.H.J. Danser (Rotterdam, The Netherlands)

11.15 • INAPPROPRIATE LV MASS DURING ANTIHYPERTENSIVE TREATMENTADVERSELY AFFECTS CARDIOVASCULAR PROGNOSIS IN HYPERTENSIVEPATIENTS WITH LEFT VENTRICULAR HYPERTROPHYM.L. Muiesan, M. Salvetti, A. Paini, C. Monteduro, P. Poisa, B. Bonzi, G. Galbassini,D. Rizzoni, M. Castellano, E. Agabiti Rosei (Brescia, Italy)

11.30 • ABNORMAL EXERCISE BLOOD PRESSURE PREDICTS LEFT VENTRICULARMASS IN PREHYPERTENSIVESA.E. Pittaras, P.F. Kokkinos*, V. Papademetriou*, P. Narayan*, D. Manjoros*, G.D. Kolovou, S. Singh*, A.J. Manolis (Athens, Greece; *Washington, DC, USA)

11.45 • MYOCARDIAL FIBROSIS ASSESSED BY C-TERMINAL PROPEPTIDE OFPROCOLLAGEN TYPE I IS INCREASED IN HYPERTENSIVE LEFT VENTRICULARHYPERTROPHY, AND IS REDUCED BY ANTIHYPERTENSIVE TREATMENTT. Kahan, J. Diez*, B. Lopez*, A Gonzalez*, R. Müller-Brunotte, M. Edner, K. Malmqvist (Stockholm, Sweden; *Pamplona, Spain)

12.00 • COMPENSATORY OR INAPPROPRIATE LEFT VENTRICULAR MASS INDIFFERENT MODELS OF LEFT VENTRICULAR PRESSURE OVERLOADG.F. Mureddu, G. Cioffi*, C. Stefenelli*, G. de Simone** (Rome, *Trento, **Naples,Italy)

12.15 • MAST CELL NUMBER AND ACTIVITY ARE INCREASED IN THE PRESSURE-OVERLOADED HEARTR. Tozzi, A. Facoetti, G. Palladini, C. Gatti, I. Ferrero, F. Clari, R. Nano, G. Busca*,A.U. Ferrari*, S. Perlini* (Pavia, *Milan, Italy)


HeartOral Session 2A


Chairmen:A. Semplicini (Padua, Italy)T. Unger (Berlin, Germany)

11.00 • EFFECTS OF IRBESARTAN VERSUS ATENOLOL ON VASCULAR STIFFNESSAND AORTIC BLOOD PRESSURE IN ESSENTIAL HYPERTENSIONM.P. Schneider, A.U. Klingbeil, C. Delles, M. Ludwig*, R.E. Kolloch**, M. Krekler***,K.O. Stumpe*, R.E. Schmieder (Nürnberg, *Bonn, **Bielefeld, ***München,Germany)

11.15 • DIFFERING ADMINISTRATION TIME-DEPENDENT EFFECTS OF LOW-DOSEASPIRIN ON AMBULATORY BLOOD PRESSURE IN DIPPER AND NON-DIPPERHYPERTENSIVE SUBJECTSR. Hermida, D.E. Ayala, C. Calvo*, M. Covelo*, M. Rodríguez*, A. Mojón, J.R. Fernández, I. Alonso, J.E. López* (Vigo, *Santiago, Spain)

11.30 • INFLUENCE OF TELMISARTAN HYDROCHLOROTHIAZIDE COMBINATIONON COGNITIVE FUNCTION IN ELDERLY HYPERTENSIVE PATIENTSR. Fogari, A. Mugellini, L. Corradi, M. Destro, C. Pasotti, A. Zoppi, A. Rinaldi(Pavia, Italy)

11.45 • NEBIVOLOL DECREASES OXIDATIVE STRESS IN ESSENTIALHYPERTENSIVE PATIENTS AND INCREASES NITRIC OXIDE BY REDUCING ITSOXIDATIVE INACTIVATIONC. Stranieri, M.C. Nava, A. Fratta Pasini, U. Garbin, A. Davoli, V. Lo Cascio, L. Cominacini (Verona, Italy)

12.00 • FACTORS INFLUENCING THE EFFECT OF STATINS ON BLOOD PRESSUREIN HYPERTENSIVE PATIENTSC. Borghi, M.G. Prandin, A. Dormi, M. Veronesi, E.R. Cosentino, E. Ambrosioni(Bologna, Italy)

12.15 • ANGIOTENSIN CONVERTING ENZYME INHIBITION IMPROVES CLINICALSYMPTOMS IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASEA.A. Ahimastos, A. Lawler, P.A. Blombery, B.A. Kingwell (Melbourne, Australia)


Experimental Pharmacologyand TherapeuticsOral Session 2B


Chairmen:A. Izzard (Manchester, UK)D. Hayoz (Lausanne, Switzerland)

11.00 • THE RELATIVE EFFECTS OF RENIN ANGIOTENSIN SYSTEM AND THE ADRENERGIC SYSTEM ON VASCULAR REMODELINGR. Smith, H. Yokoyama, D. Averill, E. Schiffrin*, C. Ferrario (Winston-Salem, NC,USA; *Montreal, Canada)

11.15 • MIDDLE CEREBRAL ARTERY STRUCTURAL CHANGES DURINGDEVELOPING AND ESTABLISHED HYPERTENSION IN THE SPONTANEOUSLYHYPERTENSIVE RATA. Izzard, S. Horton, E. Heerkens, L. Shaw, A. Heagerty (Manchester, UK)

11.30 • MAXIMAL CONTRACTIONS IN RESISTANCE ARTERIES OF NORMOTENSIVEBLACK AND WHITE WOMENL. Brewster, S. Volger, J. Clark*, E. van Bavel, H. Wolf, G. van Montfrans(Amsterdam, The Netherlands; *Cincinnati, OH, USA)

11.45 • IN-VIVO ARTERIOLAR CONSTRICTOR RESPONSES TO ANGIOTENSIN II INMAN CORRELATE INVERSELY WITH BLOOD PRESSUREN. Berger, P. de Leeuw, J. Burgwinkel, A. Birkenhager, A. Houben (Maastricht, The Netherlands)

12.00 • INTERLEUKIN 6 IS ASSOCIATED WITH ATHEROSCLEROSIS IN A LOW RISKPOPULATION - A LINK WITH SOLUBLE INTER CELLULAR ADHESION MOLECULE-1J. Amar, J. Fauvel, L. Drouet*, V. Bongard, J.B. Ruidavets, B. Perret, B. Chamontin, H. Boccalon, J. Ferrieres (Toulouse, *Paris, France)

12.15 • PROTEOLYTIC REGULATION IN ACCELERATED ATHEROSCLEROSIS ANDANEURYSMS IN HUMANSE. Kaschina, H. Scholz, M. Sommerfeld, S. Schmidt, U. Vosgerau, N. Doerfel, U. Kintscher, T. Unger (Berlin, Germany)


Blood VesselsOral Session 2C


Chairmen:A. Benetos (Nancy, France)A.C. Pessina (Padua, Italy)

11.00 • PROGNOSTIC SIGNIFICANCE OF NIGHT-TIME, EARLY MORNING ANDDAYTIME BLOOD PRESSURES ON THE RISKS OF CEREBRO ANDCARDIOVASCULAR MORTALITYH. Metoki, T. Ohkubo, M. Kikuya, K. Asayama, T. Obara, J. Hashimoto, K. Totsune, H. Hoshi*, H. Satoh, Y. Imai (Sendai, *Ohasama, Japan)

11.15 • RISK OF CARDIOVASCULAR AND ALL CAUSE MORTALITY IN PATIENTSWITH “WHITE COAT” OR “MASKED” HYPERTENSION: AN 11 YEAR FOLLOW-UPFROM THE PAMELA STUDYG. Mancia, R. Facchetti, M. Bombelli, H. Polo Friz, G. Grassi, R. Sega (Milan, Italy)

11.30 • AMBULATORY BLOOD PRESSURE MONITORING AND RISK OFCARDIOVASCULAR DISEASET. Hansen, J. Jeppesen, S. Rasmussen, H. Ibsen, C. Torp-Pedersen (Copenhagen,Denmark)

11.45 • HOME BLOOD PRESSURE MEASUREMENT LEADS TO REDUCTION OF TREATMENT WITHOUT BEING ACCOMPANIED BY WORSE OFFICE BLOODPRESSURE LEVEL OR DEVELOPMENT OF ORGAN DAMAGE RESULTS OF THEHOMERUS-TRIALW.J. Verberk, A.A. Kroon, A.G.H. Kessels, C. Dirksen, P.J. Nelemans, J.W.M. Lenders*,Th. Thien*, G.A. van Montfrans**, A.J. Smit***, P.W. de Leeuw (Maastricht,*Nijmegen, **Amsterdam, ***Groningen, The Netherlands)

12.00 • A COMPARISON OF HOME MEASUREMENT AND AMBULATORYMONITORING OF BLOOD PRESSURE IN THE ADJUSTMENT OFANTIHYPERTENSIVE TREATMENTT. Niiranen, M. Ruuska, J. Johansson, I. Kantola (Turku, Finland)

12.15 • WEB-BASED TELEMONITORING OF HOME BLOOD PRESSURE IN GENERALPRACTICE: THE MOREPRESS-COLLEGE STUDYG. Parati, S. Omboni*, A. Fantoni*, E. Puglisi*, G. Caldara, A. Giglio, G. Mancia(Milan, *Varese, Italy)

Saturday, June 18 Blue Hall11.00-12.30

Blood Pressure Measurement and HaemodynamicsOral Session 2D


12.30-13.30 How to identify peripheral artery disease

Chairman:D.L. Clement (Gent, Belgium)

Discussants:M. De Buyzere (Gent, Belgium)E. Rietzchel (Gent, Belgium)B. Waeber (Lausanne, Switzerland)

Saturday, June 18Red Hall 1

“How to” Session


12.30-13.30 How to correctly identify and quantifymicroalbuminuria

Chairman:J. Redon (Valencia, Spain)


“How to” Session


12.30-14.00 Chairman :P.A. van Zwieten (Amsterdam, TheNetherlands)

Diagnosis and management of cardiacarrhythmiasA. Manolis (Athens, Greece)

Mild to severe renal damage. Implication forcardiovascular risk and treatmentA. Wiecek (Katowice, Poland)

Resistant hypertension: definition andmanagementS. Erdine (Istanbul, Turkey)


Teaching Seminar - Session 1


1 • NT-proBNP PLASMA CONCENTRATIONS ARE ELEVATED IN BLACK AFRICANPATIENTS WITH MODERATE-TO-SEVERE HYPERTENSIONE. Libahaber, H. Abbasi, K. Sliwa, C. Toyin, G. Norton, A. Woodiwiss, C. Libhaber, R. Essop (Johannesburg, South Africa)

2 • TWO DIFFERENT SENSOR LOCATIONS FOR THE BEAT-TO-BEATMEASUREMENT OF CONTINUOUS NON-INVASIVE BLOOD PRESSURE BYDETERMINING PULSE WAVE VELOCITY AND TRANSIT TIME: ARE THEYEQUIVALENT?M.H. Brem, P. Boll*, N. Lutter (Erlangen, *Karlsruhe, Germany)

3 • FOREARM BLOOD PRESSURE MEASUREMENT: COMPARISON WITH ARMMEASUREMENTM. Milmaniene, A. Cormillot, E. Sarcona, M. Diaz (Buenos Aires, Argentina)

4 • THE PROGNOSTIC VALUE OF HOME BLOOD PRESSURE AND OFFICE BLOODPRESSURE IN HYPERTENSIVE PATIENTSS.T. Solomou, A.A. Grivas, M.P. Psilogiannopoulos, E.E. Anagnostakis (Athens,Greece)

5 • PREVALENCE AND REPRODUCIBILITY OF MASKED HYPERTENSION IN URBANJAPANESE GENERAL POPULATION - EVALUATION BY HOME BLOOD PRESSUREMEASUREMENT OVER A 6-MONTHS PERIODH. Kawabe, I. Saito, T. Saruta (Tokyo, Japan)

6 • CLINICAL CHARACTERISTICS OF SUBJECTS WITH MASKED HYPERTENSIONAND WHITE COAT HYPERTENSION - COMPARISON WITH HYPERTENSIVES ANDNORMOTENSIVESK. Stolarz, A. Olszanecka, G. Bilo, W. Lubaszewski, B. Wizner, T. Grodzicki, K. Kawecka-Jaszcz (Cracow, Poland)

7 • ARTERIAL CHARACTERISTICS IN NORMOTENSIVE OFFSPRING WITHPARENTAL HISTORY OF HYPERTENSIONJ. Kucerova, J.A. Staessen*, M. Cwynar**, T. Kuznetsova*, K. Stolarz**, W. Wojciechowska**, M. Ticha, R. Fagard*, T. Grodzicki**, J. Filipovsky(Pilzen, Czech Republic; *Leuven, Belgium; **Cracow, Poland)

8 • COMPARISON OF TWO SPHYGMOMANOMETERS THAT MAY REPLACEMERCURY IN THE HEALTHCARE WORKPLACEW. Elliott, L. DeVivo, J. Feldstein*, H. Black (Chicago, *East Hanover, USA)

9 • IMPROVED REPRODUCIBILITY OF THE DIPPER CLASSIFICATION INHYPERTENSION WITH 48-HOUR AMBULATORY BLOOD PRESSURE MONITORINGR. Hermida, D.E. Ayala, C. Calvo*, A. Mojón, J.R. Fernández, I. Alonso, J.E. López*(Vigo, *Santiago, Spain)

10 • AUTONOMIC MODULATION AND HEMODYNAMICS DURING POST-RESISTANCE EXERCISE HYPOTENSIONC. Rezk, R. Marrache*, T. Tinucci*, D. Mion Jr.*, C. Forjaz* (Osasco, *São Paulo,Brazil)

Saturday, June 18 Ground Floor12.30-15.30

Blood Pressure Measurement and HemodynamicsPoster Session 1


11 • ACCURACY OF A WRIST BLOOD PRESSURE MONITOR: COMPARAISON WITHINTRA-ARTERIAL PRESSUREF.J. Sanchez, P. Morillas, V. Bertomeu, J.M. Ruiz, A. Frutos, P. Carrillo, D. Nuñez, J. Quiles, R. Valero, J.A. Rodriguez (San Juan, Spain)

12 • ARTERIAL COMPLIANCE AND INSULIN RESISTANCE IN HYPERTENSIVEPATIENTS WITH AND WITHOUT DIABETES MELLITUS TYPE IIS. Oren, B. Golzman, J. Kogan, S. Turkot, I. Isakov, R. Peled (Ashkelon, Israel)

13 • FACTORS AFFECTING THE DIFFERENCE BETWEEN CLINIC AND HOME BLOOD PRESSURE MEASUREMENTS IN TREATED HYPERTENSIVE PATIENTSM.A. Martínez, T. Sancho, I. Laguna, J.M. Rubio, F.J. Cirujano, A. Torre, F.J. Palau, J.G. Puig, on behalf of MAPA Working Group (Madrid, Spain)

14 • WHICH PERIDIALYSIS BLOOD PRESSURE BEST PREDICTS INTERDIALYTICLEVEL?Y. Bataille, A. Saint-Remy, E. Godon*, B. Dubois, J.M. Krzesinski (Liege, *Huy, Belgium)

15 • PREVALENCE OF HOME BLOOD PRESSURE MEASUREMENT AMONGSELECTED HYPERTENSIVE PATIENTS: RESULTS OF A MULTICENTER SURVEYFROM SIX HOSPITAL OUT-PATIENT HYPERTENSION CLINICS IN LOMBARDYV. Fusi, C. Cuspidi, S. Meani, L. Lonati, G. Garavelli*, G. Palumbo**, C. Pini***, A. Vaccarella****, G. Parati, G. Leonetti, A. Zanchetti (Milan, *Cremona,**Legnano-MI, ***Como, ****Casatenovo-LC, Italy)

16 • ARE PUBLISHED CHARACTERISTICS OF THE AMBULATORY BLOODPRESSURE GENERALIZABLE TO RURAL CHINESE?Y. Li, J.G. Wang, P.J. Gao, H.F. Guo, T. Nawrot*, G.L. Wang, Y.S. Qian, J.A. Staessen*,D.L. Zhu (Shanghai, China; *Leuven, Belgium)

17 • THE BLOCKADE OF RENIN-ANGIOTENSIN SYSTEM RESTRICTS STRESS-INDUCED HAEMODYNAMIC REACTIONS IN HYPERTENSIVE PATIENTS WITHINCREASED CIRCADIAN BLOOD PRESSURE VARIABILITYA. Barsukov, S. Shoustov, M. Al-Yasidi (St. Petersburg, Russia)

18 • CHEMOREFLEX AND METABOREFLEX CONTROL DURING STATIC HYPOXICEXERCISEA. Houssiere, B. Najem, A. Ciarka, S. Velez-Roa, R. Naeije, P. van de Borne(Bruxelles, Belgium)

19 • MONOTHERAPY AGAINST COMBINATION THERAPY IN ELDERLY PATIENTSWITH HYPERTENSIONS. Antonopoulos, S. Mikros, S. Kokkoris, Th. Nitsotolis, G. Chrysos, Gr. Giannoulis (Piraeus, Greece)

20 • NEW TOOLS FOR ESTIMATING MEAN ARTERIAL PRESSURE IN RADIALARTERY AND ASCENDING AORTA: THE HARMONIC AND GEOMETRIC AVERAGE OFSYSTOLIC AND DIASTOLIC PRESSURED. Chemla, A. Nitenberg, P. Valensi, H. Le Clesiau*, M. Brahimi (Paris , *Bobigny,France)

21 • ISOLATED AMBULATORY HYPERTENSION AND CHANGES IN TARGET ORGANDAMAGE IN TREATED HYPERTENSIVE PATIENTSC. Cuspidi, S. Meani, V. Fusi, C. Valerio, E. Catini, F. Magrini, A. Zanchetti (Milan, Italy)

22 • RELATIONSHIP BETWEEN LEFT VENTRICULAR EJECTION TIME AND THESYSTOLIC PRESSURE AMPLIFICATION FROM ASCENDING AORTA TO RADIALARTERY IN MENM. Brahimi, P. Valensi, H. Le Clesiau*, A. Nitenberg, D. Chemla (Paris, *Bobigny,France)


23 • RELATIONSHIP BETWEEN MEAN PRESSURE AND THE INDICES OF PULSATILITYIN THE ASCENDING AORTA: THE GEOMETRIC MEAN AORTIC PRESSURED. Chemla, I. Antony, K. Zamani, A. Nitenberg (Paris, France)

24 • ISOLATED UNCONTROLLED HYPERTENSION AT HOME AND IN THE OFFICEAMONG TREATED HYPERTENSIVE PATIENTS FROM THE J-HOME STUDYT. Obara, T. Ohkubo, J. Funahashi, M. Kikuya, K. Asayama, H. Metoki, T. Oikawa, J. Hashimoto, K. Totsune, Y. Imai (Sendai, Japan)

25 • A NEW VECTOR INDEX FOR STATISTICAL ASSESSMENT OFANTIHYPERTENSIVE TREATMENT DURATION AND HOMOGENEITYM. Aboy, J.R. Fernández, R. Hermida (Vigo, Spain)

26 • CARDIOVASCULAR OUTCOME IN TREATED HYPERTENSIVE PATIENTS WITHTRUE AND FALSE RESPONDER HYPERTENSIONS. Pierdomenico, D. Lapenna, A. Bucci, R. Di Tommaso, B. Manente, F. Cuccurullo,(Chieti, Italy)

27 • RELATIONSHIP BETWEEN THE DIASTOLIC DYSFUNCTION AND THE PULSEPRESSURE IN TREATED HYPERTENSIVE PATIENTSC. Podoleanu, D. Podoleanu, A. Incze, E. Carasca (Targu Mures, Romania)

28 • CLINICAL UTILITY OF TELE-BP MONITORING IN SECONDARY HYPERTENSION(OSAS AND RENOVASCULAR HYPERTENSION)B. Benczúr, M. Illyés*, A. Nagy (Kecskemét, *Budapest, Hungary)

29 • NEPHROPROTECTIVE AND ORGANOPROTECTIVE EFFICACY OF MOEXIPRIL INPATIENTS WITH MILD TO MODERATE HYPERTENSIONM. Demidova, M. Leonova, Y. Belousov, A. Tarasov (Moscow, Russia)

30 • HYPONATREMIC-HYPERTENSIVE SYNDROME CAUSED BY RENOVASCULARHYPERTENSIONE. Sulyok, Z.S. Györke, Á. Hartmann, P. Degrell, I. Wittmann (Pécs, Hungary)

31 • CUFF INFLATION INDUCES A GREATER REACTIVE RISE IN BLOOD PRESSUREWHEN PLACED AT THE ARM THAN AT THE WRIST IN HYPERTENSIVE PATIENTSA. Charmoy, C. Hassler, F. Cachat, C. Ruffieux, B. Waeber, M. Burnier (Lausanne,Switzerland)

32 • ACTIVATION OF P2Y-RECEPTORS INCREASE ANGIOTENSIN II-INDUCEDVASOCONSTRICTIONM. Toelle, G. Giebing, W. Zidek, M. van der Giet (Berlin, Germany)

33 • PREDICTABLE CHANGES IN THE DAY/NIGHT BLOOD PRESSURE RATIO WITHAGING IN UNTREATED PATIENTS WITH ESSENTIAL HYPERTENSIONR. Hermida, C. Calvo*, D.E. Ayala, M. Covelo*, M. Rodríguez*, A. Mojón, J.R. Fernández, I. Alonso, M.J. Fontao, R. Soler, J.E. López* (Vigo, *Santiago, Spain)

34 • CHRONOTHERAPY IN HYPERTENSION - THE CRONOPRES PROJECTInvestigators of the CRONOPRES Project (Sehlelha, Spain)

35 • THE OCCURRENCE OF THE ALERTING RESPONSE IS INDEPENDENT OFMETHOD OF BLOOD PRESSURE MEASUREMENTJ. Graves, B. Grossardt, R. Gullerud, K. Bailey, J. Feldstein* (Rochester, MN, *EastHannover, USA)

36 • INTERMITTENT SELF-MONITORING OF BLOOD PRESSURE AT HOMEDECREASES BLOOD PRESSURE AND PROMOTES THE ACHIEVEMENT OF THETARGET PRESSURE IN PRIMARY CARE SETTINGI. Kantola, L. Halme, M. Kaaja*, R. Vesalainen, HOMER Study Group** (Turku,*Kuopio, **Finland Primary Health Care Centers, Finland)


37 • ARE THE WRIST BLOOD PRESSURE DEVICES ACCURATE FOR THEDIAGNOSIS OF HYPERTENSION?P. Morillas, V. Bertomeu, F.J. Sánchez, J.M. Ruiz, A. Frutos, P. Carrillo, J. Quiles, D. Nuñez, R. Valero, J.A. Rodriguez (San Juan, Spain)

38 • WAIST CIRCUMFERENCE BUT NOT BODY MASS INDEX NEGATIVELYINFLUENCES THE DIPPER PHENOMENONR. Fabregate, E. Sanchez-Largo, B. Monge, O. Sanchez, D. Coca, E. Bernal, M. Fabregate, A. Ugalde, A. Trueba, J. Saban-Ruiz (Madrid, Spain)

39 • INTIMA-MEDIA THICKNESS, ELASTICITY AND FLOW-MEDIATED DILATATIONIN DIPPER AND NON-DIPPER SUBJECTSJ. Saban-Ruiz, E. Bernal, B. Monge, J. Haurie, M. Fabregate, D. Coca, O. Sanchez, R. Fabregate, E. Sanchez-Largo, A. Ugalde (Madrid, Spain)

40 • THE AMBULATORY BLOOD PRESSURE PATTERN IN PATIENTS WITHRESISTANT HYPERTENSION IS MARKEDLY AFFECTED BY THE TIME OFANTIHYPERTENSIVE TREATMENTR. Hermida, D.E. Ayala, C. Calvo*, M. Covelo*, M. Rodríguez*, A. Mojón, J.R. Fernández, I. Alonso, M.J. Fontao, R. Soler, J.E. López* (Vigo, *Santiago, Spain)

41 • INFLUENCE OF STATIN TREATMENT ON BLOOD PRESSURE AND HEART RATEVARIABILITIES EVALUATED BY AMBULATORY MONITORINGO. Sanchez, M. Fabregate, D. Coca, A. Ugalde, E. Bernal, R. Fabregate, B. Monge, E. Sanchez-Largo, J. Marquez, J. Saban-Ruiz (Madrid, Spain)

42 • RECOGNITION OF INDIVIDUAL NIGHT-TIME DIRECTLY FROM ABPM DATA ASA BASIS FOR ACCURATE AUTOMATIC ANALYSISS.E. Pekarski, V.F. Mordovin, M.V. Kolodina, G.V. Semke, T.M. Ripp, S.V. Triss (Tomsk, Russia)

43 • DISCREPANCY BETWEEN HOME AND AMBULATORY BLOOD PRESSURECONTROL: A POSSIBLE SELF ALARM EFFECT ?B. Vaisse, F. Silhol, K. Bouchlaghem, E. Fattacinni (Marseille, France)

44 • HIGH PREVALENCE AND POOR CONTROL OF HYPERTENSION IN THEPRIMARY CARE OF THE CZECH REPUBLICJ. Widimsky Sr, M. Soucek*, M. Sachova, V. Lanska (Prague, *Brno, Czech Republic)

45 • ANKLE BRACHIAL INDEX MEASUREMENT: CONCORDANCE STUDY BETWEENDOPPLER AND OSCILLOMETRIC DEVICEE. Vinyoles, J.M. Casermeiro, V. Salido, C. de Prado, E. Pujol, M. de la Figuera, S. Jabalera(Sant Adrià de Besòs, Spain)

46 • ETHNIC DIFFERENCES IN ARTERIAL STIFFNESS AND WAVE REFLECTIONSAFTER CIGARETTE SMOKINGD. Lemogoum, J.R. M’Buyamba-Kabangu**, M. Leeman, L. Van Bortel*, J.P. Degaute,Ph. van de Borne (Brussels, *Gent, Belgium; **Kinshasa, Zaire)

47 • ANTHROPOMETRIC, METABOLIC AND HAEMODYNAMIC DIFFERENCESBETWEEN RISER AND NON-DIPPER SUBJECTSJ. Saban-Ruiz, E. Bernal, M. Fabregate, R. Fabregate, O. Sanchez, E. Sanchez-Largo,D. Coca, B. Monge, A. Ugalde (Madrid, Spain)

48 • EVALUATION OF BLOOD PRESSURE CONTROL IN TREATED HYPERTENSIVE PATIENTS. WHEN AND HOW CLINIC BLOOD PRESSURE SHOULD BE MEASURED?R. Hermida, D.E. Ayala, C. Calvo*, M.J. Fontao, R. Soler, M. Covelo*, M. Rodríguez*,J.E. López* (Vigo, *Santiago, Spain)


49 • INFLUENCE OF LEFT VENTRICULAR HYPERTROPHY ON MYOCARDIALFUNCTION IN ATHLETES AND HYPERTENSIVES HEART - ASSESSMENT BYDOPPLER TISSUE IMAGINGM. Deljanin Ilic, S. Ilic, V. Ilic, Lj. Nikolic, D. Djordjevic (Niska Banja, Yugoslavia)

50 • DOPPLER TISSUE VELOCITY SAMPLING DETECTS SUPER-SILENTMYOCARDIAL ISCHEMIA IN HYPERTENSIVE PATIENTSS. Ilic, M. Deljanin Ilic, Lj. Nikolic, B. Ilic (Niska Banja, Yugoslavia)

51 • THE INCREASED LEFT VENTRICULAR MASS IN PATIENTS AFTER KIDNEYTRANSPLANTATION WITH ADVANCED CHRONIC PERIODONTITIS IS NOTDEPENDENT ON IL-6, TNF-ALPHA, OR INSULIN SENSITIVITYE. Franek, A. Blach*, J. Chudek*, A. Kolonko*, A. Witula*, J. Drugacz*, F. Kokot*, A. Wiecek* (Warszawa, *Katowice, Poland)

52 • CORRELATION BETWEEN P-WAVE SIGNAL AVERAGEDELECTROCARDIOGRAPHY AND ECOCARDIOGRAPHIC CHANGES IN HYPERTENSIVEPATIENTSD. Toader, R. Musetescu, A. Musetescu, D.D. Ionescu (Craiova, Romania)

53 • P-WAVE SIGNAL AVERAGED ELECTROCARDIOGRAPHY IN EVALUATION THERISK OF ATRIAL FIBRILLATION IN HYPERTENSIVE PATIENTSD. Toader, R. Musetescu, D.D. Ionescu (Craiova, Romania)

54 • T-344C POLYMORPHISM OF ALDOSTERONE SYNTHASE GENE ANDCARDIOVASOPROTECTIVE EFFICIENCY OF ENALAPRIL IN PATIENTS WITHESSENTIAL HYPERTENSIONG. Khamidullaeva, N. Sirojiddinova, G. Abdullaeva, M. Eliseyeva, B. Adilov (Tashkent,Uzbekistan)

55 • CARDIAC VASOPRESSIN SYSTEM DURING RAT MATURATIONJ. Gutkowska, M. Miszkurka, M. Marcinkiewicz, M. Jankowski (Montreal, Canada)

56 • MECHANISMS OF ATRIAL NATRIURETIC PEPTIDE RELEASE BY MOXONIDINEFROM ISOLATED RAT HEARTSS. Mukaddam-Daher, A. Menaouar, J. Gutkowska (Montreal, Canada)

57 • PUROMYCIN AMINONUCLEOSIDE (PAN)-INDUCED NEPHROTIC SYNDROME IS ACCOMPANIED WITH CARDIAC CACHEXIA AND ALTERED LEFT VENTRICULARHEMODYNAMIC AND MOLECULAR PARAMETERSM. Moreira-Rodrigues, R. Roncon-Albuquerque Jr., T. Henriques-Coelho, B. Sampaio-Maia, A. Leite-Moreira, M. Pestana (Porto, Portugal)

58 • LEFT VENTRICULAR CONTRACTILITY DECREASE IN HYPERTENSIVEPATIENTS WITH LEFT VENTRICULAR HYPERTROPHY AS COMPARED TOHYPERTROPHIC CARDIOMYOPATHYA. Linhart, T. Palecek, Z. Hlubocka, K. Taborska, L. Golan, A. Bani Hani, V. Danzig, M. Aschermann (Prague, Czech Republic)


HeartPoster Session 2


59 • LEFT VENTRICULAR DIASTOLIC DYSFUNCTION ASSESSED BY PULSED TDI IS ACCOMPANIED BY INCREASED AORTIC STIFFNESS IN THE EARLY STAGES OFESSENTIAL HYPERTENSIOND. Chatzis, C. Tsioufis, P. Stougiannos, A. Kakkavas, I. Vlasseros, K. Dimitriadis, C. Stefanadis, I. Kallikazaros (Athens, Greece)

60 • DIAGNOSIS OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION WITH TISSUEDOPPLER ECHOCARDIOGRAPHYA. Safarova, D. Basgopal, Y. Karaulova, Y. Kotovkaya, E. Korovina, Zh. Kobalava(Moscow, Russia)

61 • CHARACTERISTICS AND FIVE YEARS PROGNOSIS OF HYPERTENSIVEPATIENTS WITH DIFFERENT VALUES OF LYON-SOKOLOW SCORED. Djordjevic, B. Lovic, M. Deljanin Ilic, S. Ilic, I. Tasic (Niska Banja, Yugoslavia)

62 • THE EFFECT OF PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTYON PLASMA NT-PROBNP CONCENTRATIONS IN HYPERTENSIVE ANDNORMOTENSIVE SUBJECTS WITH AND WITHOUT SYSTOLIC LEFT VENTRICULARDYSFUNCTIONU. Brzezinska, N.E. El Mohktari*, R. Simon*, A. Tykarski (Poznan, Poland; *Kiel,Germany)

63 • EVALUATION OF LEFT VENTRICULAR HYPERTROPHY REGRESSION INDUCEDBY CANDESARTAN USING THE CORNELL VOLTAGE DURATION PRODUCTELECTROCARDIOGRAPHIC CRITERIA. THE VIPE STUDYA. Calderón, V. Barrios, J.P. Tomás, J.L. Moya, A. Megias, S. Ruiz, L.M. Molinero,O. Vegazo, R. Fernandez, E. Asín (Madrid, Spain)

64 • IMPACT OF LONG-TERM SPIRINOLACTONE TREATMENT ON REGIONALMYOCARDIAL FUNCTION IN HYPERTENSIVE PATIENTSM. Deljanin Ilic, S. Ilic, I. Tasic, B. Lovic (Niska Banja, Yugoslavia)

65 • INCREASED LEVELS OF URINARY ALBUMIN EXCRETION ARE ACCOMPANIEDBY ADVERSE LEFT VENTRICULAR GEOMETRIC ADAPTATIONS IN ESSENTIALHYPERTENSIVE PATIENTS WITHOUT LEFT VENTRICULAR HYPERTROPHYK. Dimitriadis, C. Tsioufis, P. Stougiannos, A. Mariolis, V. Chatzistamatiou, I. Vlasseros,C. Stefanadis, I. Kallikazaros (Athens, Greece)

66 • THE BENEFICIAL EFFECTS OF CANDESARTAN ON LEFT VENTRICULARGEOMETRY ARE NOT ASSOCIATED TO CHANGES IN DIASTOLIC FUNCTION ATSHORT TERM. THE VIPE STUDYV. Barrios, A. Calderón, J.P. Tomás, S. Ruiz, J.L. Moya, A. Megías, C. Escobar, L.M. Molinero, O. Vegazo, R. Fernández, E. Asín (Madrid, Spain)

67 • ECHOCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY REGRESSIONINDUCED BY CANDESARTAN IN CLINICAL PRACTICE. THE VIPE STUDYV. Barrios, A. Calderón, J.P. Tomás, S. Ruiz, J.L. Moya, A. Megías, C. Escobar, L.M. Molinero, O. Vegazo, R. Fernández, E. Asín (Madrid, Spain)

68 • A NEW TECHNIQUE FOR QUANTITATIVE ASSESSMENT OF THE HEART INHYPERTENSIONE. Miyajima, Y. Shintani, H. Yonezawa, S. Sumita (Yokohama, Japan)

69 • AGE-ASSOCIATED DIFFERENCES IN LEFT ATRIAL SIZE AND FUNCTION INARTERIAL HYPERTENSIONG. Cioffi, G.F. Mureddu*, C. Stefenelli, G. de Simone** (Trento, *Rome, **Naples,Italy)


70 • EVALUATION OF MYOCARDIAL DAMAGE IN DAHL SALT-SENSITIVEHYPERTENSIVE RATS WITH SYSTOLIC HEART FAILURE BY ASSESSINGMYOCARDIAL Tc-99m SESTAMIBI WASHOUTK. Fukushima, M. Senda, K. Fukuchi*, Y. Ishida*, N. Okamoto**, H. Kurosawa***,S. Hayashi, K. Sugimura (Kobe, *Suita, **Shinjuku, ***Sanbu, Japan)

71 • INCREASED ARTERIAL WAVE REFLECTIONS AND PROLONGED MECHANICALSYSTOLE IN DIASTOLIC DYSFUNCTIONT. Weber, J. Auer, M.F. O`Rourke*, C. Punzengruber, B. Eber (Wels, Austria;*Sydney, Australia)

72 • THE CORNELL VOLTAGE DURATION PRODUCT IS THE MOST USEFUL ELECTROCARDIOGRAPHIC CRITERION FOR THE DETECTION OF LEFTVENTRICULAR HYPERTROPHY. THE ELECTROTENS STUDYV. Barrios, A. Calderón, A. Amador, C. Escobar, L. Ribas*, E. Asín (Madrid,*Barcelona, Spain)

73 • ARTERIAL STIFFNESS AND CARDIOVASCULAR RISK FACTORS IN ESSENTIALARTERIAL HYPERTENSIONV. Aursulesei, G. Datcu, M.D. Datcu (Iasi, Romania)

74 • LEFT ATRIAL SYSTOLIC FUNCTION IN PATIENTS WITH ARTERIALHYPERTENSIONI. Moyssakis, D. Papadopoulos, E. Gialafos, A. Zilidis, I. Paizis, V. Votteas (Athens,Greece)

75 • THE LEFT VENTRICULAR FUNCTIONALITY IN ARTERIAL HYPERTENSIONASSESSED THROUGH THE PERFORMANCE MYOCARDIAL INDEX CALCULATED BYTHE TISSULAR DOPPLER ECHOCARDIOGRAPHYM. D’Avino, A. Arciello, D. Caruso, E. Manfredi, G. Caruso, F. Cacciapuoti (Naples,Italy)

76 • INFLUENCE OF BLOOD PRESSURE VARIABILITY ON THE COURSE ANDPROGNOSIS OF MYOCARDIAL INFARCTIONV. Tseluyko, S. Karlov (Kharkov, Ukraine)

77 • PREVALENCE OF CARDIOVASCULAR RISK FACTORS IN KUWAITF. Al Assomi (Kuwait City, Kuwait)

78 • CHANGES OF STRESS INDEX AND OTHER HEART RATE VARIABILITYPARAMETERS IN HYPERTENSION TREATMENTZ. Trefny, J. Svacinka, R. Bayevski*, M. Loucka, S. Trojan, J. Slavicek, S. Herczegh (Prague, Czech Republic; *Moscow, Russia)

79 • MORNING RISE IN BLOOD PRESSURE IS A PREDICTOR OF LEFTVENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS TREATED WITHAMLODIPINE MONOTHERAPYT. Ikeda, M. Hayashida, J. Okada, M. Ikeda, T. Gomi*, Y. Shibuya, K. Matsuo, N. Oku,S. Kinugasa (Tokyo, Japan)

80 • HYPERTENSION DOES NOT PREDICT THE RISK OF ATRIAL FIBRILLATIONAFTER CARDIAC SURGERYJ. Auer, R. Berent, T. Weber, G. Lamm, C.K. Ng, R. Puschmann, B. Eber (Wels, Austria)


81 • EFFECT OF NAD(P)H OXIDASE INHIBITION ON ANGIOTENSIN II-STIMULATEDCOLLAGEN PRODUCTION IN ADULT RAT CARDIAC FIBROBLASTSI. Papparella, G. Ceolotto, V. Petrov*, R. Fagard*, A. Semplicini, P. Lijnen* (Padua,Italy; *Leuven, Belgium)

82 • COMPARISON OF THE EFFECTS OF DOSAGE AND DELIVERY PERIOD IN THEADMINISTRATION OF CANDESARTAN ON CARDIAC FUNCTION AND THEPROLONGING OF SURVIVAL IN DAHL SALT-SENSITIVE HYPERTENSIVE RATS WITHSYSTOLIC HEART FAILUREK. Fukushima, S. Kawashima, M. Kawai, S. Hayashi, K. Sugimura (Kobe, Japan)

83 • CENTRAL ACTION OF ANGIOTENSIN II AND THE DEVELOPMENT OF DIETARYOBESITYK. Rahmouni, W.G. Haynes, C.D. Sigmund (Iowa City, IA, USA)

84 • RENIN-ANGIOTENSIN SYSTEM BLOCKADE EFFECTS ON IMPROVEMENT OFADVANCED RENAL DAMAGES IN HIGH-AGED SPONTANEOUSLY HYPERTENSIVERATS VIA SUPPRESSION OF OXIDIZED STRESSN. Ito, M. Ohishi, K. Yamamoto, M. Kaibe, Y. Takagi, M. Terai, Y. Tatara, H. Rakugi, T. Ogihara (Suita, Japan)

85 • CIRCULAR DICHROISM SPECTROSCOPIC ANALYSIS AND CO-LOCALIZATIONOF N-DOMAIN ANGIOTENSIN-I CONVERTING ENZYME WITH ANGIOTENSIN II ANDANGIOTENSIN 1-7 IN MESANGIAL CELLS FROM WISTAR AND SPONTANEOUSLYHYPERTENSIVE RATSM.C.C. Andrade, G.S. Di Marco, V.P.C. Teixeira, R.A. Mortara, R. Affonso, I.D.C. Guerreiro da Silva, F.L. Plavnick, D.E. Casarini (São Paulo, Brazil)

86 • ANGIOTENSIN II SUPPRESSES TNF-ALPHA INDUCED IL-6 EXPRESSION VIATHE AT2-RECEPTOR IN HUMAN DERMAL FIBROBLASTSJ. Reinemund, M. Artuc, B.M. Henz, Th. Unger, U.M. Steckelings (Berlin, Germany)

87 • TELOMERASE (hTERT) EXPRESSION IN BENIGN AND MALIGNANTALDOSTERONE-PRODUCING TUMORSG.P. Rossi, D. Sticchi, A. Fassina, A.S. Belloni, A.C. Pessina (Padua, Italy)

88 • MICROALBUMINURIA IN PRIMARY ALDOSTERONISM AND PRIMARYHYPERTENSIVE PATIENTS OF THE PAPY STUDYG.P. Rossi, G. Bernini, B. Fabris, C. Ferri, C. Ganzaroli, G. Giacchetti, C. Letizia, M. Maccario, F. Mallamaci, M. Mannelli, G. Palumbo, C. Pasqualetto, D. Rizzoni, E. Rossi, F. Mantero (Padua, Italy)

89 • PRIMARY ALDOSTERONISM PREVALENCE IN ITALY (PAPY) STUDY: FINALRESULTSG.P. Rossi, G. Bernini, B. Fabris, C. Ferri, C. Ganzaroli, G. Giacchetti, C. Letizia, M. Maccario, F. Mallamaci, M. Mannelli, G. Palumbo, C. Pasqualetto, D. Rizzoni, E. Rossi, F. Mantero (Padua, Italy)


Renin-Angiotensin SystemPoster Session 3


90 • DOES THE AVAILABILITY OF ADRENAL VEIN SAMPLING AFFECT THEDIAGNOSIS OF THE ADRENOCORTICAL PATHOLOGY UNDERLYING PRIMARYALDOSTERONISM? RESULTS OF THE PAPY STUDYG.P. Rossi, G. Bernini, B. Fabris, C. Ferri, C. Ganzaroli, G. Giacchetti, C. Letizia, M. Maccario, F. Mallamaci, M. Mannelli, G. Palumbo, D. Rizzoni, E. Rossi, F. Mantero (Padua, Italy)

91 • SELECTIVE ALDOSTERONE BLOCKER, EPLERENONE INCREASES CARDIAC ANGIOTENSIN 2 EXPRESSION IN SALT-SENSITIVE HYPERTENSIONY. Takeda, A. Zhu, T. Yoneda, M. Usukura, H. Takata, N. Oda, Y. Yamamoto (Kanazawa, Japan)

92 • REDUCED mRNA AND PROTEIN CONTENT OF REGULATOR OF RHO GUANINENUCLEOTIDE EXCHANGE FACTOR IN BARTTER’S AND GITELMAN’S SYNDROMES.RELEVANCE FOR THE PATHOPHYSIOLOGY OF HYPERTENSIONL.A. Calò, E. Pagnin, M. Sartori, A.C. Pessina, A. Semplicini (Padua, Italy)

93 • PREVALENCE OF PRIMARY ALDOSTERONISM AMONG HYPERTENSIVEPATIENTSP. Preti, A. Mugellini, A. Rinaldi, M. Destro, G. Marasi, L. Corradi, R. Fogari (Pavia,Italy)

94 • ALDOSTERONE/RENIN RATIO IS USEFUL TEST FOR PRIMARYALDOSTERONISMJ. Kos, A. Kovac*, I. Pecin, M. Baresic, T. Zeljkovic-Vrkic, M. Laganovic, D. Kuzmanic,B. Jelakovic (Zagreb, *Slavonski Brod, Croatia)

95 • COMPARISON BETWEEN EARLY AND DELAYED SYSTEMIC TREATMENT WITH CANDESARTAN OF RATS AFTER ISCHEMIC STROKES. Kaiser, F. Hagemann, J. Brdon, Y. Zhao, J. Culman, P. Gohlke (Kiel, Germany)

96 • INHIBITION OF THE RENIN-ANGIOTENSIN SYSTEM DOES NOT REDUCEPLATELET ACTIVITY AT REST OR DURING STRESS IN ESSENTIAL HYPERTENSIONJ.H. Schwieler, N.H. Wallén, T. Kahan, J. Nussberger*, P. Hjemdahl (Stockholm,Sweden; *Lausanne, Switzerland)

97 • ATORVASTATIN INHIBITS ACE INDUCTION IN DIFFERENTIATING HUMANMACROPHAGESF. Fyhruist, O. Saijonmaa (Helsinki, Finland)

98 • REGULATION OF ANGIOTENSIN CONVERTING ENZYME BY NICOTINE INHUMAN ENDOTHELIAL CELLSO. Saijonmaa, F. Fyhrquist (Helsinki, Finland)

99 • RENIN-ANGIOTENSIN SYSTEM POLYMORPHISMS AND ANTIHYPERTENSIVE RESPONSE TO ITS BLOCKERSA. Mayor-Olea, A. Reyes-Engel, F.J. Aranda-Lara, M.J. Gaitan, G. Callejon, M. Ruiz, P. Aranda (Malaga, Spain)

100 • HYPERKALEMIA AND BLOCKADE OF RENIN-ANGIOTENSIN SYSTEM INCHRONICALLY HEMODIALYZED PATIENTSL. Zibar, J. Barbic, J. Milas-Ahic, M. Jakic, A. Galcic (Osijek, Croatia)

101 • SIGNIFICANCE OF A LIPOPHILIC ANGIOTENSIN II RECEPTOR BLOCKER IN APROTECTIVE EFFECT AGAINST VASCULAR REMODELING: COMPARISON OFTELMISARTAN VERSUS LOSARTANS. Takai, D. Jin, M. Muramatsu, K. Yoshikawa, M. Miyazaki (Takatsuki, Japan)

102 • PRELIMINARY FINDINGS ON URINARY PROSTASIN, A POSSIBLE MARKEROF ALDOSTERONE-DEPENDENT EPITHELIAL SODIUM CHANNEL RENAL ACTIVATIONO. Olivieri, A. Castagna, G. Sabaini, L. Chiecchi, P. Guarini, P.G. Righetti (Verona, Italy)


103 • PRIMARY ALDOSTERONISM IS A FREQUENT CAUSE OF POOR BLOODPRESSURE CONTROL DESPITE TECHNICALLY SUCCESSFUL ENDOVASCULARTREATMENT OF RENAL ARTERY STENOSISF. Pizzolo, C. Pavan, P. Guarini, D. Girelli, A. Bassi, A. Corgnati, R. Corrocher, O. Olivieri (Verona, Italy)

104 • EFFECT OF ANGIOTENSIN RECEPTOR TYPE 1 BLOCKER LOSARTAN ON THECAROTID ARTERY INTIMA-MEDIA THICKNESS OF THE NEW DIAGNOSEDHYPERTENSIVE PATIENTSF. Canli Turan, H.M. Sonmez, M. Keceli (Aydin, Turkey)

105 • PLASMA LEVELS OF SOLUBLE CD40 LIGAND IN ESSENTIAL HYPERTENSIONC. Natal Gorgojo, O. Beloqui, J.A. Páramo Fernández, J. Orbe Lopategui, J. Diez Martinez, N. Vero Cenarruzabeitia (Pamplona, Spain)

106 • PROLIFERATION OF HUMAN FIBROBLASTS DEPENDS ON ACE I/DPOLYMORPHISMJ. Tyszkiewicz, J. Góra, I. Uhrynowska-Tyszkiewicz, A. Dziedzic-Goceawska, Z. Gaciong (Warsaw, Poland)

107 • THE RENIN-ANGIOTENSIN SYSTEM IS NOT DISPROPORTIONATELYSTIMULATED IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASET.W.R. Doulton, A.K. Saggar-Mallik, C. Carney, N.D. Markandu, G. Sagnella, G.A. MacGregor (London, UK)

108 • UTILITY OF PLASMA RENIN ACTIVITY AS A PREDICTOR OF PLASMAVOLUME IN FORMULATING THERAPY IN RESISTANT HYPERTENSIONM.M. Althaf, J.W. Graves (Hradec Kralove, Czech Republic; *Rochester, MN, USA)

109 • COMPARISON OF COMBINED BLOCKADE OF THE RENIN-ANGIOTENSINSYSTEM WITH A 100% INCREASE IN ANGIOTENSIN-CONVERTING INHIBITORDOSE: EFFECTS ON BLOOD PRESSURE AND PROTEINURIA IN PATIENTS WITHCHRONIC RENAL INSUFFICIENCYI. Malegos, C. Mihas (Athens, Greece)

110 • ETHNIC DIFFERENCES IN RENIN, ALDOSTERONE AND LEFT VENTRICULARMASSA. Stewart, S. Millasseau, J. Ritter, P. Chowienczyk (London, UK)

111 • SUBSETS OF ALDOSTERONE-PRODUCING ADENOMA IDENTIFIED WITHDYNAMIC ADRENAL VEIN SAMPLINGC. Ganzaroli, D. Miotto, R. De Toni, G. Palumbo*, A.C. Pessina, G.P. Rossi (Padua,*Legnano-MI, Italy)

112 • EVALUATION OF TUBULOGLOMERULAR FEEDBACK MECHANISM INPATIENTS WITH ESSENTIAL HYPERTENSIONA. Aktas, I. Atar, A. Koyuncu, M. Aras (Ankara, Turkey)

113 • HEMODYNAMIC EFFECTS OF INTRA-RENALLY INFUSED ANGIOTENSIN 1-7IN HYPERTENSIVE PATIENTS WITH AND WITHOUT RENAL ARTERY STENOSISG. Mostard, A. Houben, A. Kroon, M. Fuss-Lejeune, J. van Engelshoven, P. de Leeuw(Maastricht, The Netherlands)

114 • THE MECHANISMS OF INSULIN RESISTANCE IMPROVEMENT BYANGIOTENSIN II RECEPTOR BLOCKERN. Ura, K. Yamaguchi, N. Togashi, H. Murakami, M. Hyakukoku, K. Higashiura, K. Shimamoto (Sapporo, Japan)


115 • CHANGES IN PERFUSION PRESSURE ALTER THE ANGIOTENSIN ANDENDOTHELIN RECEPTOR EXPRESSION IN RAT MESENTERIC ARTERYI. Lindstedt, C.B. Xu, E. Nilsson, L. Edvinsson (Lund, Sweden)

116 • ERYTHROPOIETIN INCREASES THE ENDOTHELIN B RECEPTOR EXPRESSIONIN NORMAL RATSM.E. Rodrigue, R. Larivière, M. Lebel (Quebec, Canada)

117 • AEROBIC TRAINING IMPROVES CARDIOVASCULAR HEMODYNAMIC ANDSTRUCTURAL ALTERATIONS PRESENT IN OLD SHRR. Caffaro, R. Oliveira, S. do Amaral*, M. Baldo**, L. Michelini**, V. Lahera, L. Venturini Rossoni** (Madrid, Spain; *Bauru, **Sao Paulo, Brazil)

118 • LARGE TIDAL VOLUME MECHANICAL VENTILATION INDUCES VASCULARDYSFUNCTION IN RATSN. Nin, J.A. Valero, J.A. Lorente, M. de Paula, A. Sánchez-Ferrer, A. Esteban, E. Miravalles (Madrid, Spain)

119 • CHRONIC OUABAIN TREATMENT ENHANCES THE HYPERTENSION PRESENTIN SHR ACCOMPANIED BY CHANGES IN VASCULAR FUNCTIONL. Venturini Rossoni, F. Elias Xavier, C. Usuda Tanoue (Sao Paulo, Brazil)

120 • HYPOXIA/REOXYGENATION INDUCES CELL ADHESION MOLECULESEXPRESSION AND VON WILLEBRAND FACTOR RELEASE BY CULTUREDENDOTHELIAL CELLSO. Antonova, S. Loktionova, O. Shustova, A. Mazurov (Moscow, Russia)

121 • GENDER PARTICULARITIES IN CARDIOVASCULAR RESPONSIVENESS TOBLOCKADE OF NITRIC OXIDE SYNTHASE IN NORMAL AND STRESSED RATSO. Glushkovskaya-Semyachkina, T. Anishchenko, G. Kharolskaya, Yu. Tautinova(Saratov, Russia)

122 • RELATION OF C-REACTIVE PROTEIN TO OXIDATIVE STRESS AND TOENDOTHELIAL DYSFUNCTION IN ESSENTIAL HYPERTENSIONS. Cottone, A. Vadalà, M. Guarneri, R. Arsena, G. Mulè, E. Nardi, F. Vaccaro, G. Cerasola (Palermo, Italy)

123 • THE ROLE OF ENDOTHELIAL DYSFUNCTION UNDER ARTERIALHYPERTENSION WITH INSULIN RESISTANCE SYNDROMEM. Orynchak, E. Neyko, O. Chovganyuk (Ivano-Frankivsk, Ukraine)

124 • THE BACKSTAGE OF THE PATIENT WITH ELEVATED HIGH SENSITIVITY C-REACTIVE PROTEIN LEVELSJ. Saban-Ruiz, J. Marquez, E. Sanchez-Largo, D. Coca, O. Sanchez, E. Bernal, A. Ugalde, M. Calbacho, R. Fabregate, M. Fabregate (Madrid, Spain)

125 • CONTROL OF ENDOTHELIAL VASODILATOR POTENCY BY REACTIVE OXYGENSPECIES IN ACUTE HYPOTENSIONT. Westhoff, M. Toelle, S. Schmidt, W. Zidek, M. van der Giet (Berlin, Germany)


EndotheliumPoster Session 4


126 • HORMONE REPLACEMENT THERAPY AND ENDOTHELIAL FUNCTION INHYPERTENSIVE POSTMENOPAUSAL WOMENO. Bolshakov, E. Baranova, O. Kolesnik, A. Katsap (St. Petersburg, Russia)

127 • EFFECTS OF ERYTHROPOIETIN ON RETINAL CAPILLARY FLOW IN HUMANST. Schäufele, J. Harazny, S. Oehmer, C. Delles, G. Michelson, R.E. Schmieder(Erlangen, Germany)

128 • ASSESSMENT OF CORONARY MICROCIRCULATION BY PERFUSIONCARDIOVASCULAR MAGNETIC RESONANCE IN PATIENTS WITH ARTERIALHYPERTENSION AND LEFT VENTRICULAR HYPERTROPHY - PRELIMINARYRESULTSK. Kawecka-Jaszcz, A. Olszanecka, D. Czarnecka, M. Pasowicz, P. Klimeczek,R. Banys, A. Klecha, K. Stolarz, A. Kwiecien-Sobstel (Kraków, Poland)

129 • BENEFICIAL EFFECT OF T-TYPE CALCIUM CHANNEL ANTAGONIST ONENDOTHELIAL FUNCTION IN PATIENTS WITH ESSENTIAL HYPERTENSIONT. Oshima, R. Ozono, M. Kambe, Y. Watari, Y. Yano, Y. Yamamoto (Hiroshima, Japan)

130 • ENDOTHELIUM-DEPENDENT MICROVASCULAR FUNCTION IS RELATED TOAGE BUT NOT TO BLOOD PRESSURE OR INSULIN SENSITIVITYM.A. James, J. Tullett, A.G. Hemsley, A.C. Shore (Exeter, UK)

131 • DIVERSE ASSOCIATIONS OF MICROALBUMINURIA WITH C-REACTIVEPROTEIN, INTERLEUKIN-18 AND SOLUBLE CD 40 LIGAND IN MALE ESSENTIALHYPERTENSIVE SUBJECTSK. Dimitriadis, C. Tsioufis, D. Chatzis, P. Stoygiannos, A. Kakkavas, A. Mariolis, C. Stefanadis, I. Kallikazaros (Athens, Greece)

132 • EVALUATION OF ENDOTHELIAL FUNCTION IN SALT-SENSITIVE ESSENTIALHYPERTENSIONI. Andronikashvili, M. Kutateladze, G. Simonia (Tbilisi, Georgia)

133 • IMPAIRED PERIPHERAL VASOREACTIVITY IN STROKE PATIENTSA. Stenborg, A. Terent, L. Lind (Uppsala, Sweden)

134 • A COMPARISON OF EFFECTS OF PHYSICAL TRAINING AND MEDICALTHERAPY ON ENDOTHELIAL FUNCTION IN PATIENTS WITH HYPERTENSIONT. Pronko (Grodno, Belarus)

135 • COMPARISON OF THE TWO NON-INVASIVE METHODS OF ENDOTHELIALFUNCTION EVALUATIONA. Semyonkin, A. Novikov, Yu. Novikov, V. Kolokolov, A. Nazarov, I. Protsky, L. Zhivilova, E. Radul, T. Pritykina, V. Potapov (Omsk, Russia)

136 • THE EFFECT OF ATORVASTATIN ON VASOMOTOR RESPONSESP. Tretjakovs, A. Jurka, A. Stifts*, J. Aivars, A. Jansone, V. Pirags (Riga, Latvia)

137 • MARKERS OF ENDOTHELIAL DYSFUNCTION BEFORE AND AFTERADRENALECTOMY IN PATIENTS WITH ALDOSTERONE PRODUCING ADENOMAO. Petrak, J. Widimsky, J. Kvasnicka, J. Mrazkova-Bilkova, T. Zelinka, B. Strauch, J. Skrha (Prague, Czech Republic)

138 • DRUGS WITH BLOCKING EFFECTS ON RENIN-ANGIOTENSIN-ALDOSTERONESYSTEM CAN NOT IMPROVE ENDOTHELIAL DYSFUNCTION LONG-TERMM. Mertoglu, G. Kocabey, H. Oflaz, S. Vatansever, O. Erk, V. Akkaya, K. Güler, M. Dilmener, S. Demirel (Istanbul, Turkey)


139 • HABITUAL PHYSICAL ACTIVITY, ARTERIAL STIFFNESS AND ENDOTHELIALFUNCTION IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTSY. Plantinga, L. Ghiadoni, A. Magagna, M. Bernardini, S. Taddei, A. Salvetti (Pisa, Italy)

140 • LEFT VENTRICULAR CONCENTRIC REMODELING IS ACCOMPANIED BYAUGMENTED LEVELS OF INFLAMMATORY MARKERS IN ESSENTIALHYPERTENSIVE PATIENTS: AN INTRIGUING LINKP. Stougiannos, C. Tsioufis, M. Toutouza, D. Chatzis, E. Taxiarchou, I. Vlasseros, A. Kakkavas, P. Missovoulos, C. Stefanadis, I. Kallikazaros (Athens, Greece)

141 • THE ASSESSMENT OF ALBUMINURIA IN HYPERTENSIVE PATIENTS WITHLEFT VENTRICULAR SYSTOLIC DYSFUNCTION AFTER TREATMENT WITHCARVEDILOLUM AND TELMISARTANM. Moise, C. Tudorica, M. Muraru, D. Spataru, A. Stoica, I. Bruckner (Bucharest,Romania)


142 • TREATMENT WITH MOXONIDINE FOR RESISTANT HYPERTENSIONN.R. Robles, S. Barroso, B. Cancho, M.V. Martin, E. Sanchez Casado (Badajoz, Spain)

143 • COMPARATIVE EVALUATION OF ENDOTHELIAL AND METABOLIC EFFECTSOF INDAPAMIDE AND HYDROCHLOROTHIAZIDE IN HYPERTENSIVE PATIENTSL. Zhivilova, A. Semyonkin, Z. Golyevtsova, L. Mikhailova, I. Protsky, A. Nazarov, T. Pritykina, I. Kudryashov, V. Chernakova (Omsk, Russia)

144 • SPIRONOLACTONE AND SPIRONOLACTONE PLUS ENALAPRIL ORLOSARTAN, EFFECT ON BLOOD PRESSURE AND POTASSIUM IN HYPERTENSIONR. Suarez-Otero, S. Valdez-Mendoza (Toluca, Mexico)

145 • REINDUCTION RATE WITH LERCANIDIPINE IN PATIENTS WHO HAVESTOPPED TREATMENT WITH DIHYDROPYRIDINE BECAUSE OF LOWER LIMBOEDEMAF. Allaert, C. Causse*, N. Vernet (Dijon, *Castres, France)

146 • CHRONOTHERAPY IMPROVES BLOOD PRESSURE CONTROL AND REVERTSTHE NON-DIPPER PATTERN IN PATIENTS WITH RESISTANT HYPERTENSIONC. Calvo, R. Hermida*, D.E. Ayala*, M. Covelo, J.E. Lopez (Santiago, *Vigo, Spain)

147 • DISSPARATE EFFECT OF ACE INHIBITOR AND THIAZIDE DIURETIC ONINSULIN SENSITIVITY IN POSTMENOPAUSAL HYPERTENSIVE WOMENACCORDING TO HORMONE REPLACEMENT THERAPY TAKINGA. Posadzy-Malaczynska, J. Gluszek, A. Tykarski (Poznan, Poland)

148 • EFFECTS OF CANDESARTAN AND AMLODIPINE ON OXIDIZED LOW-DENSITYLIPOPROTEIN LEVEL IN PATIENTS WITH MILD TO MODERATE ESSENTIALHYPERTENSIONP. Muda, P. Kampus, R. Teesalu, K. Zilmer, T. Ristimäe, K. Fischer, M. Zilmer(Tartu, Estonia)

149 • INFLUENCE OF CANDESARTAN ON ENDOTHELIAL FUNCTION IN PATIENTSWITH MITRAL STENOSIS AND ARTERIAL HYPERTENSIONM. Orynchak, E. Neyko, O. Paliy, M. Rozhko (Ivano-Frankivsk, Ukraine)

150 • INFLUENCE OF LOSARTAN OR AMLODIPINE THERAPY ON THE LEFTVENTRICULAR REMODELLING AND RENAL FUNCTION IN ESSENTIALHYPERTENSIONS. Tolpyguina, E. Oschepkova, L. Sergakova, A. Rogoza, T. Kotkina (Moskow, Russia)

151 • ERECTILE DYSFUNCTION DURING HYPERTENSION MANAGEMENT: OLDERvs NEWER DRUGSA. Micheli, M. Doumas, A. Tsakiris*, S. Douma*, A. Hounta*, Ang. Papadopoulos*,A. Tatara, N. Spathari, M. Souli*, I. Mihailidou*, H. Giamarellou (Alexandroupolis,*Athens, Greece)

152 • ETHNICITY IS A STRONG PREDICTOR OF SYSTOLIC BLOOD PRESSURELOWERING IN A DUTCH MULTI-ETHNIC POPULATIONP. van Rijn-Bikker, G. Mairuhu, G. van Montfrans, R. Koopmans (Amsterdam, The Netherlands)


Pharmacology andTherapeuticsPoster Session 5


153 • A SIMILAR 24H BLOOD PRESSURE CONTROL IS OBTAINED BY ZOFENOPRILAND CANDESARTAN IN ESSENTIAL HYPERTENSIVE PATIENTSG. Leonetti, A. Rappelli*, S. Omboni** (Milan, *Ancona, **Varese, Italy)

154 • HYPERTENSION TREATMENT IN NONDIABETIC ADVANCED CHRONIC KIDNEYDISEASE PATIENTS WITH IRBESARTAN. EFFECT ON SERUM URIC ACIDF. Coronel, S. Cigarran, J.A. Herrero, N. Calvo, M. Garcia Mena (Madrid, Spain)

155 • ASSESSMENT OF THE ANTIHYPERTENSIVE EFFICACY OF LINIPRIL USING24-H AMBULATORY MONITORINGD. Raev, B. Georgiev, V. Bajcheva, I. Ivanov, N. Gocheva (Sofia, Bulgaria)

156 • CLINICAL EFFICIENCY OF ENALAPRIL IN PATIENTS WITH ESSENTIALHYPERTENSION WITH ACCOUNT I/D - POLYMORPHISM OF ACE GENEG. Abdullaeva, M. Eliseyeva, B. Karimova, R. Bekbulatova (Tashkent, Uzbekistan)

157 • ENDOTHELIUM PROTECTION EFFICIENCY OF MONOTHERAPY WITHEPROSARTAN IN PATIENTS WITH ESSENTIAL HYPERTENSIONB. Karimova, M. Eliseyeva, D. Kurbanova, N. Sirojiddinova (Tashkent, Uzbekistan)

158 • NORMALIZED DIASTOLIC BLOOD PRESSURE, PRIOR STROKE ANDASSOCIATED RISK FACTORS ARE OBSTACLES TO IMPROVING SYSTOLIC BLOODPRESSUREJ. Amar, J.P. Cambou, S. Quentzel*, N. Danchin** (Toulouse, *Rueil-Malmaison,**Paris, France)

159 • HYPOTENSION EFFECT OF ARIFON-RETARD 1.5 MG AMONG PATIENTSWITH ENDOTHELIAL DYSFUNCTIONT. Ripp, V. Mordovin, G. Semke, S. Pekarski, M. Kolodina, R. Karpov (Tomsk,Russia)

160 • HEART RATE VARIABILITY AND BLOOD PRESSURE DAILY PROFILE UNDERTREATMENT WITH BETAXOLOL IN PATIENTS WITH ESSENTIAL HYPERTENSIONT. Ovdiienko (Kiev, Ukraine)

161 • EFFICIENCY OF THE COMBINED THERAPY IN ARTERIAL HYPERTENSIONCOMPLICATED BY CHRONICAL ATRIAL FIBRILLATION WITH ENAP-HL,METOPROLOL AND ISOPTIN SRG. Savenkova, S. Popov, I. Antonchenko, I. Kurlov, R. Batalov (Tomsk, Russia)

162 • THE POTENT VASODILATOR MINOXIDIL IS OFTEN EFFECTIVE INCONTROLLING BLOOD PRESSURE IN REFRACTORY HYPERTENSIONR.N.A. Black, S.J. Hunter, A.B. Atkinson (Belfast, UK)

163 • DOES DOXAZOSIN INCREASE SYMPATHETIC TONE?N. van der Linde, F. Boomsma, A. van den Meiracker (Rotterdam, The Netherlands)

164 • RESPONSES OF PLASMA ALDOSTERONE TO USUAL ANTIHYPERTENSIVEDOSES OF THE DIURETIC TORASEMIDE IN HEALTHY SUBJECTSA.J. Reyes, W.P. Leary* (Montevideo, Uruguay, *Cork, Ireland)

165 • ANTIHYPERTENSIVE THERAPY WITH DIURETICS AND CARBOHYDRATEMETABOLISMM. Diaz, M.E. Díaz (Montevideo, Uruguay)

166 • ACUTE EFFECTS OF TEA ON FASTING AND POSTPRANDIAL VASCULARFUNCTION AND BLOOD PRESSURE IN HUMANSJ.M. Hodgson, V. Burke, I.B. Puddey (Perth, Australia)


167 • COMPARISON OF ANTIHYPERTENSIVE EFFICACY OF CONVENTIONALMETOPROLOL TARTARATE VERSUS SLOW-RELEASE FORMULATION OFMETOPROLOL TARTARATE USING AMBULATORY BLOOD PRESSURE MONITORINGD. Raev (Sofia, Bulgaria)

168 • DIFFERENTIAL EFFECTS OF MORNING VS EVENING DOSING OF RAMIPRILIN HYPERTENSIVE CHILDREN WITH CHRONIC RENAL FAILUREC. Hadtstein, E. Wühl, O. Mehls, F. Schaefer, and ESCAPE Trial Group (Heidelberg,Germany)

169 • COMPLIANCE TO ANTIHYPERTENSIVE TREATMENT AND MONOTHERAPY.BEHAVIOUR OF THE CALCIUM-CHANNEL BLOCKER LERCANIDIPINEC. Borghi, M.G. Prandin, F.V. Costa, A. Dormi, S. Bacchelli, V. Immordino, M. Veronesi,E. Ambrosioni (Bologna, Italy)

170 • SEVERE HYPERTENSION IN THE EMERGENCY ROOM: A STEPPEDTREATMENT PROTOCOL IN A NATIONAL MULTICENTER STUDYC. Kotliar, P. Rodriguez*, P. Forcada*, M. O’Flaherty, D. Turri, M. Diaz*, H. Fernandez,M. Pellizzari, M. Bendersky*, D. Grassi** (Pilar, *Buenos Aires, **on behalf ofREHASE Investigators, Buenos Aires, Argentina)

171 • EFFECTS OF DROSPIRENONE/ESTRADIOL, A NOVEL HORMONE THERAPYWITH ALDOSTERONE ANTAGONIST ACTIVITY, ON BLOOD PRESSURE, RENALFUNCTION, AND POTASSIUM BALANCE IN HIGH RISK HYPERTENSION SUBGROUPSR.A. Preston, W.B. White*, B. Pitt**, P.M. Norris, V. Hanes*** (Miami, FL,*Farmington, CT, **Ann Arbor, MI, ***Montville, USA)

172 • NINE MONTHS FOLLOW-UP OF AMLODIPINE MALEATE AND AMLODIPINEBESYLATE TREATMENT IN PATIENTS WITH ESSENTIAL HYPERTENSION: DOES THESALT FORM MATTER?M. Boh, A. Januszewicz*, M. Makowiecka-Ciesla*, A. Prejbisz*, T. Grodzicki**, B. Patera-Górnikiewicz***, A. Tykarski****, K. Widecka°, A. Wiecek°°, B. Wyrzykowski°°° (Novo Mesto, Slovenia; *Warsaw, **Kraków, ***Elblag,****Poznan, °Szczecin, °°Katowice, °°°Gdansk, Poland)

173 • ISOLATED SYSTOLIC HYPERTENSION CONTROL WITH EPROSARTAN.EPROHSA STUDYJ. Abellán, A. Divisón, F. Hernández Menárguez, A. Martínez Pastor, J.A. García-Galbis, P. Gómez Jara, R. López Guillén, on behalf of EPROHSAInvestigators (Murcia, Spain)

174 • THE EFFECTS OF RED WINE ON AMBULATORY BLOOD PRESSURE IN PRE-MENOPAUSAL WOMEN: A CONTROLLED INTERVENTION STUDYI.B. Puddey, T.A. Mori, V. Burke, D. Dunbar, L.J. Beilin (Nedlands, Australia)

175 • TRENDS IN TREATMENT AND CONTROL OF HYPERTENSION IN GENERALHOSPITAL IN JAPANT. Gomi, N. Oku, T. Kinugasa, Y. Shibuya, T. Ikeda (Tokyo, Japan)


176 • “RECEPTOR-ASSOCIATED PRORENIN SYSTEM” CONTRIBUTES TOHYPERTENSIVE END-ORGAN DAMAGEA. Ichihara, Y. Kaneshiro, T. Takemitsu, F. Suzuki*, T. Nakagawa*, A. Nishiyama**,H. Iwata*, Y. Ishida, T. Inagami***, T. Saruta, M. Hayashi (Tokyo, *Gifu, **Kagawa,Japan; ***Nashville, TN, USA)

177 • THE EFFECT OF SMOKING ON CARDIOVASCULAR RISK FACTORS ANDANTIHYPERTENSIVE THERAPYN. Jablonska, K. Lapinska-Knypl, A. Doboszynska, A. Cezak (Warsaw, Poland)

178 • PREVENTIVE EFFECTS OF GRAPEFRUIT JUICE ON PROGRESSION OFATHEROSCLEROSIS IN APO-E KNOCKOUT MICEI. Ichiyama, T. Asai, M. Watanabe, Y. Kitahara, Y. Sato, S. Kanbe, S. Harasawa, K. Okubo, R. Hisaki, H. Fujita, A. Takahashi, H. Abeta, F. Saito, Y. Otsuka, T. Kushiro(Tokyo, Japan)

179 • QUALITY ASSURANCE METHODOLOGY TO CARDIOVASCULAR RISKFACTORS CONTROLS IN PRIMARY CAREM.A. Gomez Marcos, L. Garcia Ortiz, L.J. Gonzalez Elena, E. Rodriguez Sanchez, L. Melón Barrientos, C. Herrero Rodriguez, A. Mendoza Petite, P. Bodega Sanchez,J. Parra Sanchez, A. Morales Sanchez, L. Marin Cid, L. Gonzalez Sanchez, A. Garcia Garcia, W. Amaral Calvacante, N. Mozo Gonzalez (Salamanca, Spain)

180 • PULSE-PRESSURE PREDICTS TRANSIENT MYOCARDIAL PERFUSIONABNORMALITIES DURING DIPYRIDAMOLE STRESS TESTT. Molnar, Z. Szabo, T. Szakmany, E. Udvaros, E. Schmidt, K. Zambo, A. Cziraki (Pecs, Hungary)

181 • COMBINED USE OF DIROTON AND DETRALEX IN HYPERCHOLESTEROLEMICPATIENTS WITH ARTERIAL HYPERTENSIONI. Alizade, N. Aliyeva-Karayeva (Baku, Azerbaijan)

182 • THE ADDITIONAL VALUE OF MEASURING CAROTID INTIMA MEDIATHICKNESS, PULSE WAVE VELOCITY AND AMBULATORY BLOOD PRESSURE: THE DIAGNOSIS OF RENAL ARTERY STENOSIS AS AN EXAMPLEM. van Onna, A. Kroon, A. Houben, M. Fuss-Lejeune, P. de Leeuw (Maastricht, The Netherlands)

183 • ELECTRONIC MONITORING OF DRUG ADHERENCE IMPROVES BLOODPRESSURE CONTROL IN HYPERTENSION: A RANDOMIZED, CONTROLLED STUDYV. Santschi, C. Ruffieux, O. Bugnon, M. Burnier (Lausanne, Switzerland)

184 • PLATELET ACTIVATION AND MICROAGGREGATES FORMATION INDUCED BYSHEAR IN HYPERTENSIVE PATIENTS. EFFECT OF DOXAZOSIN GITSM. Martínez, M. Labiós, F. Gabriel, V. Guiral, M. Simó, M.A. Hernández-Presa*, J. Aznar (Valencia, *Madrid, Spain)


Clinical Aspects andCardiovascular RiskPoster Session 6


185 • THE ROLE OF RAISED BRAIN NATRIURETIC PEPTIDE PLASMA LEVELS ANDLEFT ATRIAL DIMENSION IN HYPERTENSIVE PATIENTS VULNERABLE FORPAROXYSMAL ATRIAL FIBRILLATIONA. Hatziyianni, C. Tsioufis, M. Toutouza, C. Vasiliadi, J. Kallikazaros, C. Stefanadis, P. Toutouzas (Athens, Greece)

186 • ROUTINE FUNDUSCOPY TO ASSESS ORGAN DAMAGE IN PATIENTS WITHHYPERTENSION IS NOT USEFUL - A SYSTEMATIC REVIEWB.J.H. van den Born, C.A. Hulsman, J.B.L. Hoekstra, R.O. Schlingemann, G.A. van Montfrans (Amsterdam, The Netherlands)

187 • PICXEL: COLLAGEN BALANCE IMPROVEMENT WITHPERINDOPRIL/INDAPAMIDE IN HYPERTENSIVE PATIENTS WITH LEFTVENTRICULAR HYPERTROPHYJ.P. Baguet, P. Garnero*, P. Gosse**, J.M. Mallion, B. Dahlöf*** (Grenoble, *Lyon,**Bordeaux, France; ***Göteborg, Sweden)

188 • PICXEL: PERINDOPRIL /INDAPAMIDE 24-HOUR ABPM EFFICACY INHYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHYR. Asmar, Y. Karpov*, P. Gosse**, J. García-Puig***, L. Matos****, P.W. de Leeuw°,

R. Schmieder°°, D. Magometschnigg°°°, B. Dahlöf°°°° (Paris, **Bordeaux, France;*Moscow, Russia; ***Madrid, Spain; ****Budapest, Hungary; °Maastricht, TheNetherlands; °°Erlangen, Germany; °°°Wien, Austria; °°°°Göteborg, Sweden)

189 • CONTROL OF MICROALBUMINURIA IN ELDERLY PATIENTS WITH ARTERIALHYPERTENSIONG. Yarmuhamedova (Tashkent, Uzbekistan)

190 • CARDIOVASCULAR RISK SCORES, AGREEMENTS AND DISCREPANCIESBETWEEN FRAMINGHAM, REGICOR AND SCOREL. Garcia Ortiz, M.A. Gomez Marcos, L.J. Gonzalez Elena, A. Mendoza Petite, E. Rodriguez Sanchez, L. Melón Barrientos, C. Herrero Rodriguez, P. Bodega Sanchez,A. Morales Sanchez, L. Martin Cid, L. Gonzalez Sanchez, C. Rodriguez Martin, C. Castaño Sanchez, N. Carrillo Peña, P. Olivares Mesonero (Salamanca, Spain)

191 • PRE-HYPERTENSION IS ASSOCIATED WITH HIGH PREVALENCE OFCORONARY ARTERY CALCIUM IN ASYMPTOMATIC SUBJECTSE. Grossman, S. Segev, N. Morag-Koren, Y. Sharabi, J. Shemesh (Tel-Hashomer,Israel)

192 • TREATMENT OF HIGH RISK HYPERTENSIVE PATIENTS IN DAILY CLINICALPRACTICE. THE TARVEST STUDYV. Barrios, M. de la Figuera*, R. Gabriel, R. Hernández, A. Calderón**, L.M. Ruilope,J. Redón*** (Madrid, *Barcelona, **San Sebastián de los Reyes, ***Valencia, Spain)

193 • CAN HS-CRP LEVELS PREDICT THE NUMBER AND SEVERITY OF TARGETORGAN DAMAGE IN ESSENTIAL HYPERTENSION?F. Ozerkan, S. Akyuz, O. Ozdogan, B. Kirilmaz, M.R. Onder (Izmir, Turkey)

194 • CARDIOVASCULAR FACTORS ASSOCIATED WITH MICROALBUMINURIA INNON-DIABETIC PATIENTS WITH RESISTANT HYPERTENSIONA. Nogueira, E. Muxfeldt, G. Salles, K. Bloch (Rio de Janeiro, Brazil)

195 • CAROTID ARTERY DAMAGE IN HYPERTENSIVES IS AGE-DEPENDENT ANDAPPEARS EARLIER IN MENA. Tsakiris, M. Doumas, N. Nearchou, C. Kouremenou, I. Papadakis, P. Marnelos, V. Nikolaou, P. Skoufas (Athens, Greece)


196 • BLOOD PRESSURE AND LIPID CONTROL RATES ACCORDING TO THE RISKPROFILE IN A HYPERTENSIVE POPULATION ATTENDED IN PRIMARY CARE. THEPRESCOT STUDYV. Barrios, J.L. Llisterri*, A. Calderón**, E. Alegría***, J. Muñiz°, A. Matalí°°, R. de Castellar°° (Madrid, *Valencia, **San Sebastián de los Reyes, ***Pamplona,°La Coruña, °°Barcelona, Spain)

197 • MEASUREMENT AND JUDGEMENT OF HOME BLOOD PRESSUREE. Strocchi, N. Fiumi, P.L. Malini, E. Ambrosioni (Bologna, Italy)

198 • THE MOST USEFUL DIAGNOSTIC APPROACH FOR THE DETECTION OFTARGET ORGAN DAMAGE IN HYPERTENSIVE TYPE 2 DIABETICS AND THE MAINPREDICTIVE FACTORS. THE CARDHIAC STUDYA. Calderón, V. Barrios, J.P. Tomás, M.J. Manzano, M.A. Hernandez-Presa (Madrid,Spain)

199 • ERECTILE DYSFUNCTION IN ESSENTIAL HYPERTENSION: FACTORSINFLUENCING ITS APPEARANCEA. Micheli, M. Doumas, A. Tsakiris*, S. Douma*, A. Hounta*, Ang. Papadopoulos*,A. Tatara, N. Spathari, D. Plahouras*, D. Kavatha*, H. Giamarellou*(Alexandroupolis, *Athens, Greece)

200 • QT-DISPERSION AND LEFT VENTRICULAR HYPERTROPHY IN ELDERLYHYPERTENSIVE AND NORMOTENSIVE PATIENTSS. Dimopoulos, F. Nicosia*, P. Donati*, P. Prometti*, R. Zulli* (Athens, Greece;*Brescia, Italy)

201 • THE POSITIVE RELATIONSHIP BETWEEN ANKLE-BRACHIAL INDEX ANDCARDIOVASCULAR RISK IS INDEPENDENT OF AGEA. Tsakiris, M. Doumas, N. Nearchou, I. Papadakis, C. Kouremenou, P. Marnelos, X. Krinos, P. Skoufas (Athens, Greece)

202 • THE EFFECT OF BLOOD PRESSURE REDUCTION ON ANKLE-BRACHIALINDEXA. Tsakiris, M. Doumas, N. Nearchou, I. Papadakis, C. Kouremenou, P. Marnelos, X. Krinos, P. Sloufas (Athens, Greece)

203 • AORTIC COARCTATION SUSPECTED BY ECHO-DOPPLER OF RENALARTERIES IN HYPERTENSIVE PATIENTS REFERRED TO A HOSPITAL OUT-PATIENTHYPERTENSION CLINICS. Meani, C. Cuspidi, C. Valerio, E. Catini, V. Fusi, F. Magrini, A. Zanchetti (Milan,Italy)

204 • INFLAMMATORY MARKERS OF CARDIOVASCULAR RISK ASSOCIATES WITH RENOVASCULAR HYPERTENSIONJ. Nieto, M.P. Alcaide, A. Carreño, S. Anaya, S. Sánchez, F. Rivera, M.C. Vozmediano,M.D. Sánchez de la Nieta, G. Caparrós, R. Echarri, M. de la Torre (Ciudad Real, Spain)

205 • FORMATION OF SMALL SIZE PLATELET AGGREGATES AS A RISK FACTOROF THROMBOSIS IN HYPERTENSIVE PATIENTSL. Bouriachkovskaia, I. Uchitel, N. Dovlatova, T. Pogorelova, G. Potapova (Moscow,Russia)

206 • THE EFFECT OF TEVETEN ON PEROXIDE LIPID OXYDATION STATUS OFERYTHROCYTES IN HYPERTENSIVE PATIENTSI. Alizade, N. Aliyeva-Karayeva (Baku, Azerbaijan)

207 • DIAGNOSTIC RELEVANCE OF RENAL DYSFUNCTION IN HYPERTENSIVEPATIENTSE. Sarcona, M. Milmaniene, M. Diaz (Buenos Aires, Argentina)


208 • MEASUREMENT OF THE INTIMA-MEDIA THICKNESS OF THE CAROTIDARTERY: CAN IT IMPROVE THE DIAGNOSTIC VALUE OF EXERCISE STRESS TESTSIN THE DIAGNOSIS OF CORONARY ARTERY DISEASE?H. Heuten, M. Claeys, I. Goovaerts, G. Ennekens, C. Vrints (Edegem, Belgium)

209 • CRP EVOLUTION WITH ANTIHYPERTENSIVE AND STATIN TREATMENT. A FOLLOW UP STUDYE. Rodilla, J.M. Pascual, J.A. Costa, M. Arago, A. Gomez-Belda, A. Miralles, C. Gonzalez, J. Redon* (Sagunto, *Valencia, Spain)

210 • RELATIONSHIP OF SERUM FERRITIN LEVELS WITH BLOOD PRESSURE INHEALTHY MENJ.A. Papadakis, E.E. Mazokopakis, G.E. Vrentzos, M.G. Papadomanolaki, E.S. Ganotakis(Heraklion, Greece)

211 • THE NICOTINE DEPENDENCE AMONG HYPERTENSIVE PATIENTSHOSPITALIZED IN CARDIOLOGICAL DEPARTMENTN. Jablonska, K. Lapinska-Knypl, A. Doboszynska, A. Cezak (Warsaw, Poland)

212 • HIGHER BLOOD PRESSURE VARIABILITY - THE MAIN FACTOR DETERMINING CARDIOVASCULAR EFFECT OF MORNING SURGE?B. Wizner, E. Zimmer-Satora, K. Stolarz, A. Adamkiewicz-Piejko, A. Olszanecka, K. Kawecka-Jaszcz, T. Grodzicki (Cracow, Poland)

213 • THE STUDY OF PULSE PRESSURE AS AN IMPORTANT CARDIOVASCULARRISK FACTOR IN MILITARY AERONAUTICAL PERSONNELM. Anghel, M. Macri, V. Greere, C. Rusu (Bucharest, Romania)

214 • VIGILANCE STUDY : BLOOD PRESSURE CONTROL IN HYPERTENSIVEPATIENTS ACCORDING TO HISTORY OF RECENT CARDIOVASCULARCOMPLICATIONE. Ghannad, B. Vaisse*, B. Fiquet**, C. Yau**, I. De Rezola**, A. Francillon**(Gif /Yvette, *Marseille, **Rueil Malmaison, France)

215 • PREVALENCE, PRESENTATION AND LONG TERM OUTCOME OF PATIENTSWITH MALIGNANT HYPERTENSION: THE 15-YEAR EXPERIENCE OF TWOHYPERTENSION UNITS IN GREECEA. Efstratopoulos, S. Voyaki, M. Meikopoulos* (Athens, *Volos, Greece)

216 • 24-HOUR AMBULATORY PULSE PRESSURE AND LEFT ATRIAL SIZE INPATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSIOND. Raev (Sofia, Bulgaria)

217 • MECHANISMS OF THE ASSOCIATION BETWEEN CHRONIC REAL LIFESTRESS AND ELEVATED ARTERIAL PRESSURE IN HUMANSD. Lucini, G. Di Fede, M. Pagani (Milan, Italy)

218 • A NOVEL CARDIOVASCULAR RISK INDEX IN ESSENTIAL HYPERTENSIONM. Mettimano, M.L. Specchia, A. Bruno, A. Russo, A. Giuliani, S. Lippa, C. Callà, L. Savi (Rome, Italy)

219 • PULSE PRESSURE AND HEART RATE OF ARTERIAL HYPERTENSIONPATIENTS OLDER THAN 55 YEARS AFTER PHYSICAL EXERCISES. Shahvorostova, G. Molchanova, O. Belichenko (Moscow, Russia)

220 • PROGNOSTIC SIGNIFICANCE OF ORTHOSTATIC HYPOTENSION IN OLDERPATIENTS IN GENERAL PRACTICER. Fagard, P. Decort, C. Van Den Broeke (Leuven, Belgium)


221 • HYPERTENSION AND ASSOCIATED RISK FACTORS IN MILITARYAERONAUTICAL PERSONNEL - A 3-YEAR FOLLOW-UP STUDYM. Anghel, M. Macri, V. Greere (Bucharest, Romania)

222 • RELATIONSHIP OF WAIST CIRCUMFERENCE AND INSULINE RESISTANCE TOHOME BLOOD PRESSUREA. Efstratopoulos, S. Voyaki, A. Baltas, M. Meikopoulos* (Athens, *Volos, Greece)

223 • COMPARISON OF DIFFERENT TOOLS FOR CARDIOVASCULAR RISKCALCULATION IN GREEK HYPERTENSIVE PATIENTSA. Tsakiris, M. Doumas, N. Nearchou, I. Papadakis, C. Kouremenou, P. Marnelos, V. Nikolaou, P. Skoufas (Athens, Greece)

224 • CARDIOVASCULAR RISK STRATIFICATION ACCORDING TO FRENCH ANDEUROPEAN RECOMMENDATIONS IN A FRENCH HYPERTENSIVE POPULATIONS. Ragot, S. Om*, J.C. Aldigier**, D. Herpin (Poitiers, *Paris, **Limoges, France)

225 • RESPONSE TO REST IN PATIENTS WITH SEVERE HYPERTENSION:PREDICTORS OF RESPONSEM. O`Flaherty, C. Kotliar*, P. Forcada, D. Grassi, P. Rodriguez*, D. Turri, M. Diaz*, H. Fernandez, M. Pellizzari**, M. Bendersky* (Pilar, *Buenos Aires, **on behalf ofREHASE Investigators, Buenos Aires, Argentina)

226 • OBSTRUCTIVE SLEEP APNEA SYNDROME AND THORACIC AORTADISSECTION IN HYPERTENSIVE PATIENTSJ.L. Tovar, G. Sampol, A. Salas, O. Romero, P. Lloberes, T. Sagales, E. Evangelista(Barcelona, Spain)

227 • PATIENTS KNOWLEDGE ABOUT SOME DIETARY APPROACHES IN ARTERIALHYPERTENSIONS.C. Ear, S. Vereecken, A. Guldentops, M. Leeman (Brussels, Belgium)


228 • TRANSFORMING GROWTH FACTOR BETA IN HUMAN DIABETICNEPHROPATHY: EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITIONR. Langham, D. Kelly, R. Gow, Y. Zhang, D. Cordonnier*, N. Pinel*, P. Zaoui*, R. Gilbert(Melbourne, Australia, *Grenoble, France)

229 • EFFECT OF DUAL BLOCKADE OF RENIN-ANGIOTENSIN SYSTEM ONPROTEINURIAM. Barbullushi, A. Idrizi, M. Gjata, M. Tase, E. Sadiku, K. Hoti, A. Koroshi (Tirana,Albania)

230 • PREDICTORS OF MICROALBUMINURIA IN THE OLIVETTI PROSPECTIVEHEART STUDY (8-YEAR FOLLOW-UP)A. Barbato, L. D’Elia, G. Barba*, R. Iacone, O. Russo, M. Versiero, A. Siani*, F.P. Cappuccio**, F. Galletti, P. Strazzullo (Naples, *Avellino, Italy; **London, UK)

231 • BLOOD PRESSURE MODIFICATIONS IN PERITONEAL DIALYSIS PATIENTSI. Griveas, D. Papadopoulou, G. Visvardis, E. Mitsopoulos, P. Kyrikidou, E. Manou, E. Ginikopoulou, D. Meimaridou, K. Nikopoulos, G. Sakellariou (Thessaloniki, Greece)

232 • MICROALBUMINURIA IS ACCOMPANIED BY DECREASED ADIPONECTIN ANDAUGMENTED C-REACTIVE PROTEIN LEVELS IN MALE ESSENTIAL HYPERTENSIVESUBJECTSK. Dimitriadis, C. Tsioufis, C. Vasiliadou, D. Chatzis, E. Taxiarchou, E. Vezali, C. Stefanadis, I. Kallikazaros (Athens, Greece)

233 • FOLLOW UP ON HYPERTENSION, RENAL FUNCTION AND COMPLICATIONSAMONG PATIENTS WITH A RENAL ARTERY STENOSIS OF LESS THAN 50%DURING 10 YEARSC.T. Postma, H.M.E. Kruis, Th. Thien (Nijmegen, The Netherlands)

234 • CHRONIC ADMINISTRATION OF COMBINED VASOPEPTIDASE INHIBITORAND ADRENOMEDULLIN HAS RENOPROTECTIVE EFFECTS IN DAHL SALT-SENSITIVE RAT VIA INHIHIBITION OF OXIDATIVE STRESSK. Ishimura, T. Nishikimi, Y. Mori, Y. Ishikawa, H. Ono, H. Matsuoka (Mibu, Japan)

235 • LOCAL ALDOSTERONE PRODUCTION BY HUMAN RENAL MESANGIAL CELLST. Nishikawa, S. Suematsu, J. Saito, A. Soyama, H. Ito, T. Kino*, G. Chrousos*(Yokohama, Japan; *Bethesda, MD, USA)

236 • GRADED ASSOCIATION BETWEEN PLASMA LEVELS OF C-REACTIVEPROTEIN AND URINARY ALBUMIN EXCRETION IN NEWLY DIAGNOSED ESSENTIALHYPERTENSIVE SUBJECTSK. Dimitriadis, C. Tsioufis, C. Vasiliadou, G. Chartzoylakis, E. Vezali, D. Tousoulis, C. Stefanadis, I. Kallikazaros (Athens, Greece)

237 • THE EFFECT OF VALSARTAN ON SLOWING PROGRESSION OF RENALFAILURE IN HYPERTENSIVE PATIENTS WITH ADVANCED RENAL FAILUREH. Takizawa, I. Yamaji, T. Takada, Y. Oomoto, H. Murakami, S. Tanaka (Sapporo,Japan)


Renal AspectsPoster Session 7


238 • DIFFERENT EFFECTS OF ADRENERGIC RECEPTOR ANTAGONISTS AND THEANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER ON PREVENTION OFHYPERTENSIVE RENAL COMPLICATION UNDER COMPARABLE BLOOD PRESSUREREDUCTION IN SPONTANEOUSLY HYPERTENSIVE RATT. Asai, I. Ichiyama, Y. Sato, Y. Kitahara, S. Kanbe, S. Harasawa, K. Okubo, R. Hisaki,M. Koike, H. Fujita, A. Takahashi, H. Abeta, F. Saito, Y. Otsuka, T. Kushiro (Chiyoda-ku, Japan)

239 • CCAAT/ENHANCER-BINDING PROTEIN-DELTA ENHANCES MESANGIAL CELL PROLIFERATION VIA AN INDUCTION OF ITS TARGET INFLAMMATORY GENESK. Miyoshi, T. Okura, S. Manabe, J. Irita, M. Kurata, S. Watanabe, T. Fukuoka, J. Higaki(Toon, Japan)

240 • THE KIDNEY IN HYPERTENSIVE-ZINC DEFICIENT RATSC. Arranz, A. Tomat, L. Girgulsky, L. Veiras, F. Inserra, A.M. Balaszczuk, M.A. Costa (Buenos Aires, Argentina)

241 • HOMOCYSTEINE AS A FACTOR OF NEPHRO-VASCULAR RISK IN AHYPERTENSIVE POPULATIONM. D’Avino, E. De Simone, N. Bevilacqua, E. Laurella, F. Capasso, G. Caruso, D. Caruso (Naples, Italy)

242 • CONTROL RATES OF BLOOD PRESSURE AND PROTEINURIA IN PATIENTSWITH CHRONIC RENAL INSUFFICIENCY IN SPAIN. THE COPARENAL STUDYR. Marín, F. Fernández-Vega, M. Gorostidi*, L.M. Ruilope**, J. Díez***, M. Praga**,P. Herrero, C. Laviades°, P. Aranda°° (Oviedo, *Coaña, Asturias, **Madrid,***Pamplona, °Huesca, °°Málaga, Spain)

243 • SPIRONOLACTONE AND CAPTOPRIL MODULATE THIOL GROUPS IN THEKIDNEY OF L-NAME TREATED RATSO. Pechanova, J. Matuskova, D. Capikova, L. Paulis, F. Simko (Bratislava, Slovakia)

244 • RENAL DOPAMINE IN PAN-INDUCED NEPHROTIC SYNDROMEO. Azevedo-Silva, B. Sampaio-Maia, M. Moreira-Rodrigues, P. Serrao, M. Pestana (Porto, Portugal)

245 • RENAL DOPAMINE IN HgCl2-INDUCED NEPHROTIC SYNDROMEO. Azevedo-Silva, B. Sampaio-Maia, M. Moreira-Rodrigues, P. Serrao, M. Pestana (Porto, Portugal)

246 • PREDICTIVE FACTORS OF ABNORMAL CIRCADIAN BLOOD PRESSUREPROFILE IN RENO-PARENCHIMATOUS ARTERIAL HYPERTENSIONM. Voiculescu, C. Ionescu, G. Ismail, E. Galice, C. Bucsa, D. Dumitrache, M. Lixandru,S. Marin (Bucharest, Romania)

247 • HYPERHOMOCYSTEINEMIA IN HYPERTENSIVE PATIENTS WITH CHRONICRENAL INSUFFICIENCYV. Monhart, V. Hamplova, B. Choluj (Prague, Czech Republic)

248 • IS METABOLIC ALTERATION RESPONSIBLE FOR THE PROGRESSION OF IgANEPHROPATHY?T. Kovács (Pécs, Hungary)

249 • PULSE PRESSURE, RENAL FUNCTION AND MORTALITY IN BLACKHYPERTENSIVE PATIENTSJ. M’Buyamba-Kabangu, R.T. Biswika, J.R.J. M’Buyamba-Kayamba, N. Buila, D. Lemogoum* (Kinshasa, Zaire; *Brussels, Belgium)

250 • PHENYLACETIC ACID INDUCED DIFFERENTIAL EXPRESSION OF INDUCIBLENO SYNTHASE IS MEDIATED BY JNKS. Schmidt, T. Westhoff, P. Krauser, J. Jankowski, W. Zidek, M. van der Giet (Berlin, Germany)


251 • CALCIUM CHANNEL BLOCKER, AZELNIDIPINE REDUCES INSULIN-INDUCEDMESANGIAL CELL PROLIFERATION BY INHIBITING OXIDATIVE STRESSS. Manabe, T. Okura, J. Irita, M. Kurata, K. Miyoshi, T. Fukuoka, J. Higaki (Toon city,Japan)

252 • CARDIOVASCULAR RISK FACTORS IN PATIENTS ON HEMODIALYSIS,PERITONEAL DIALYSIS AND FOLLOWING KIDNEY TRANSPLANTATIONJ. Malyszko, J.S. Malyszko, M. Mysliwiec (Bialystok, Poland)

253 • MELATONIN SUPPLEMENTATION IMPROVES BLOOD PRESSURE CONTROLIN CHRONIC KIDNEY DISEASE PATIENTS WITH REFRACTORY HYPERTENSIONR. Krishnan, T.P. Naushad, G. Biju (Calicut, India)

254 • INTRA-RENAL DOPPLER FLOW PARAMETERS IN UNTREATED PATIENTSWITH UNCOMPLICATED ESSENTIAL HYPERTENSION IN RELATION TOECHOCARDIOGRAPHIC PARAMETERS AND INTIMA MEDIA THICKNESSE. Florczak, M. Januszewicz, M. Gajewska, I. Michalowska, I. Cendrowska-Demkow,A. Prejbisz, D. Rynkun, T. Rywik, K. Kraszewski, M. Makowiecka-Ciesla, M. Pielaszkiewicz, E. Mikocka, M. Kabat, P. Hoffman, A. Januszewicz (Warsaw,Poland)

255 • IS LITHIUM-INDUCED NEPHROPATHY ASSOCIATED WITH ARTERIALHYPERTENSION AND MICROALBUMINURIA?M. Vretenarska, V. Stojanova, N. Koytcheva (Sofia, Bulgaria)

256 • LONG TERM BLOOD PRESSURE CONTROL IN PERITONEAL DIALYSISPATIENTS AND ITS ASSOCIATION WITH RESIDUAL RENAL FUNCTIONI. Griveas, D. Papadopoulou, G. Visvardis, E. Mitsopoulos, P. Kyrikidou, E. Manou, E. Ginikopoulou, D. Meimaridou, K. Nikopoulos, G. Sakellariou (Thessaloniki,Greece)


257 • ALDOSTERONE AND REFRACTORY HYPERTENSIONM. Sartori, L.A. Calò, F. Cattelan, A. Realdi, V. Mascagna, L. Macchini, A. Carraro, E. Parotto, L. Ciccariello, R. De Toni, A.C. Pessina, A. Semplicini (Padua, Italy)

258 • SEX RELATED RISK FACTORS AND MAJOR CV DISEASES IN HYPERTENSIVEDIABETIC AND NON- DIABETIC PATIENTSI. Vagropoulos, M. Giavropoulou, M. Mouratova, N. Grigoriadis (Serres, Greece)

259 • ESTABLISHMENT OF SIMPLE METHODS FOR SCREENING PRIMARYALDOSTERONISM IN HYPERTENSIVE PATIENTSM. Omura, K. Fujibayashi, J. Saito, T. Saito, T. Nishikawa* (Tokyo, *Yokohama, Japan)

260 • HEART RATE VARIABILITY IN OBESE PATIENTS WITHOUT AND WITHDIABETES MELLITUS TYPE 2J. Siegelova, H. Svacinova, B. Fiser, J. Dusek, J. Jancik, L. Svoboda, I. Hruby, M. Soucek(Brno, Czech Republic)

261 • DOPAMINERGIC MODULATION OF THE CARDIOVASCULAR RESPONSE TOCOLD PRESSOR TEST IN TYPE II DIABETIC AND HYPERTENSIVE SUBJECTSF. Contreras, J. Rocaful, M. Carrucci, J. Cevallos, C. Fouillioux, G. Ibáñez, M. González,M. Velasco, G.A. Cabezas (Caracas, Venezuela)

262 • IS DOPAMINE A MODULATOR OF CARDIOVASCULAR RESPONSE IN TYPE-2DIABETIC SUBJECTS?F. Contreras, J. Rocafull, M. Carrucci, J. Cevallos, C. Fouillioux, G. Ibáñez, M. González, M. Velasco, G.A. Cabezas (Caracas, Venezuela)

263 • EFFECTS OF THE CIRCADIAN TIME OF ANTIHYPERTENSIVE TREATMENT ONTHE AMBULATORY BLOOD PRESSURE PATTERN OF HYPERTENSIVE PATIENTSWITH TYPE 2 DIABETESR. Hermida, C. Calvo*, D.E. Ayala, M. Covelo*, M. Rodríguez*, A. Mojón, J.R. Fernández, I. Alonso, M.J. Fontao, R. Soler, J.E. López* (Vigo, *Santiago, Spain)

264 • HYPERTENSION AND FIBRINOGEN IN PATIENTS WITH TYPE 2 DIABETESP. Lazzari, A. Zoppi*, R. Fogari* (Cremona, *Pavia, Italy)

265 • THE EFFECT OF ROSIGLITAZONE ON LIPOPROTEIN(a) AND HOMOCYSTEINELEVELS IN PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETESP. Sarafidis, A. Lasaridis, P. Nilsson*, A. Hitoglou-Makedou, C. Pliakos, I. Tziolas, L. Hatzistavri, P. Stafilas, A. Tourkantonis (Thessaloniki, Greece; *Malmö, Sweden)

266 • WHITE-COAT HYPERTENSION AND HOMA INDEX IN ELDERLYHYPERTENSIVE PATIENTSA. García Noain, A. Muñoz Mellado, R. Boldova Aguar, M.C. Gonzalvo Liarte, J. Mozota Duarte, A. Martinez-Berganza Asensio, P. Cia Gomez (Zaragoza, Spain)


DiabetesPoster Session 8


267 • EFFECT OF QUINAPRIL ON ARTERIAL HYPERTENSION AND MYOCARDIALMASS IN PATIENTS WITH MILD-TO-MODERATE ARTERIAL HYPERTENSION ANDTYPE 2 DIABETES MELLITUSK. Mamyrbaeva, V. Mychka, I. Chazova, V. Sinitzin (Moscow, Russia)

268 • IMPACT OF MICROALBUMINURIA ON LEFT VENTRICULAR MASS INPATIENTS WITH TYPE 2 DIABETES MELLITUSM. Picca, F. Agozzino, G.C. Pelosi (Milan, Italy)

269 • PREVALENCE OF IMPAIRED GLUCOSE METABOLISM IN PATIENTS WITHHYPERTENSIONS. Eckert, C. Vielhauer, D. Horstkotte (Bad Oeynhausen, Germany)

270 • EFFECTS OF ACUTE HYPERCALCEMIA ON BLOOD PRESSURE IN SUBJECTSWITH AND WITHOUT PARATHYROID HORMONE SECRETIONE. Kamycheva, R. Jorde, E. Haug*, G. Sager, J. Sundsfjord (Tromsø, *Oslo, Norway)

271 • ADVANCED GLYCATION ENDPRODUCTS: ISOLATION ANDCHARACTERISATION IN SALIVA FROM PATIENTS WITH DIABETES MELLITUSS. Karadogan, V. Jankowski, M. Tepel, W. Zidek, J. Jankowski (Berlin, Germany)

272 • LEFT VENTRICULAR LONG AXIS FUNCTION IS RELATED TO IMPROVEDMETABOLIC CONTROL AND REDUCED LEFT VENTRICULAR MASS IN TYPE 2DIABETIC PATIENTSN.H. Andersen, S.H. Poulsen, P.L. Poulsen, D.S. Dinesen, C.E. Mogensen (Aarhus,Denmark)

273 • HUMAN MYOCARDIAL TISSUE: ONE SOURCE OF DIADENOSINETETRAPHOSPHATE, DIADENOSINE PENTAPHOSPHATE, AND DIADENOSINEHEXAPHOSPHATEV. Jankowski, J. Luo, W. Zidek, J. Jankowski (Berlin, Germany)

274 • PHEOCHROMOCYTOMA ASSOCIATED WITH ADRENOCORTICAL ADENOMA INPATIENTS WITH NEUROFIBROMATOSIS TYPE 1C. Letizia, L. Petramala, D. Cotesta, M. Iorio, A. Cardi, S. Giustini, L. Divona, S. Calvieri, C. Caliumi (Rome, Italy)

275 • CONTROL OF HYPERTENSION AND OTHER CARDIOVASCULAR RISK FACTORSIN TYPE 2 DIABETICSB. Petrlova, H. Rosolova, L. Bartunek, P. Sifalda, I. Sipova, Z. Hess, J. Podlipny(Pilsen, Czech Republic)

276 • INCIDENCE OF PHEOCHROMOCYTOMA AND OTHER ENDOCRINE DISORDERIN PATIENTS WITH NEUROFIBROMATOSIS TYPE 1C. Letizia, L. Petramala, D. Cotesta, C. Caliumi, E. D’Erasmo, S. Filetti, L. Divona, S. Calvieri, S. Giustini (Rome, Italy)

277 • CAN TREATMENT OF PHEOCHROMOCYTOMA NORMALISE ENDOTHELIALDYSFUNCTION?J. Widimsky Jr., O. Petrak, J. Kvasnicka, J. Mrazkova-Bilkova, T. Zelinka, B. Strauch,J. Skrha (Prague, Czech Republic)

278 • METABOLIC AND CARDIAC COMPLICATIONS IN PATIENTS WITH PRIMARYALDOSTERONISM: RELATION TO SNPSG. Giacchetti, V. Ronconi, L. Agostinelli, S. Rilli, F. Turchi, F. Mantero*, M. Boscaro(Ancona, *Padua, Italy)

279 • EFFECTS OF FOUR WEEKS THERAPY WITH VALSARTAN, LISINOPRIL ANDDOXAZOSIN ON BLOOD PRESSURE, MICROALBUMINURIA AND LIPIDMETABOLISM IN DIABETIC HYPERTENSIVE PATIENTSA. Zhadan, N. Babenko (Kharkiv, Ukraine)


280 • LONG-TERM FOLLOW-UP OF PATIENTS WITH DIABETIC FOOT SYNDROME: CARDIOVASCULAR END POINTS AND PLACE OF HYPERTESIONV. Bregovsky, I. Karpova, A. Conrady (St. Petersburg, Russia)

281 • DIFFERENTIAL REGULATION OF TWO FORMS OF BRAIN NATRIURETICPEPTIDE IN ESSENTIAL HYPERTENSIVE PATIENTSP. Belluardo, A. Cataliotti*, L. Bonaiuto, E. Giuffrè, E. Maugeri, P. Noto, G. Orlando,G. Raspa, B. Piazza, D.M. Heublein*, J.C. Burnett*, L.S. Malatino (Ragusa, Italy;*Rochester, MN, USA)

282 • ARTERIAL HYPERTENSION IN CLIMACTERIC WOMENN. Yatsyshyn, R. Yatsyshyn (Ivano-Frankivsk, Ukraine)

283 • THE EFFECTS OF ALCOHOL ON BLOOD PRESSURE, HDL-C AND GLYCAEMICCONTROL IN TYPE 2 DIABETIC SUBJECTS: A CONTROLLED INTERVENTION STUDYI.B. Puddey, T.A. Mori, V. Burke, R.R. Zilkens, J.M. Hodgson, L.J. Beilin (Nedlands,Australia)

284 • MICROALBUMINURIA IS ASSOCIATED WITH CONCENTRIC LEFTVENTRICULAR HYPERTROPHY AND LOW MYOCARDIAL CONTRACTILITY INHYPERTENSIVE DIABETIC PATIENTSM. Picca, F. Agozzino, G.C. Pelosi (Milan, Italy)

285 • IMPAIRED FASTING GLUCEMIA IN NONDIABETIC HYPERTENSIVES:PREVALENCE, CLINICAL CHARACTERISTICS AND INSULIN RESISTANCEJ.I. Bernardino, M.A. Martínez, L. Gimbel, T. Mantilla, J. Suero, F.J. Castellanos, J. Sanz, P. Seguido, R. Torres, J.G. Puig, on behalf of MAPA Working Group(Madrid, Spain)

286 • PROLACTIN-DOPAMINE INTERACTIONS IN YOUNG MALES WITH ESSENTIALARTERIAL HYPERTENSIONA. Barsukov, S. Shoustov, A. Konev, O. Liventsova (St. Petersburg, Russia)

287 • PECULIARITIES OF HEART RATE CONTROL IN HYPERTENSIVE SUBJECTSWITH NON-INSULIN DEPENDENT DIABETES MELLITUSA. Vitols, D. Voita, M. Vitola (Riga, Latvia)

288 • RELATIONSHIP BETWEEN LEFT VENTRICULAR MASS REGRESSION ANDREGIONAL MYOCARDIAL FUNCTION IN HYPERTENSIVE DIABETIC PATIENTSS. Ilic, M. Deljanin Ilic, D. Petrovic, I. Tasic (Niska Banja, Yugoslavia)

289 • ASSESSMENT OF INSULIN RESISTANCE IN SUBJECTS WITH ARTERIALHYPERTENSION WITH NORMAL GLUCOSE LEVELS AND DYSGLYCEMIAI. Kondratska, B. Mankovsky (Kiev, Ukraine)

290 • AORTIC STIFFNESS CAN BE REDUCED BY INTENSIVE TREATMENT OFHYPERTENSION AND DIABETESM. Klocek, M. Rajzer, K. Kawecka-Jaszcz (Cracow, Poland)


291 • EFFECT OF MANIDIPINE-SIMVASTATIN COMBINATION ON FIBRINOLYSIS,ADHESION MOLECULES AND C-REACTIVE PROTEIN IN HYPERTENSIVEHYPERCHOLESTEROLEMIC PATIENTSR. Fogari, G. Derosa, M. Destro, L. Corradi, A. Rinaldi, C. Pasotti, A. Mugellini (Pavia, Italy)

292 • C-REACTIVE PROTEIN AND THE RISK OF DEVELOPING THE METABOLICSYNDROME. A POPULATION STUDYR. Cifkova, J. Frohlich*, Z. Skodova, V. Lanska, V. Adamkova, E. Bojanovska, M. Jozifova, M. Plaskova, M. Galovcova, D. Palous, H. Pistulkova, R. Poledne (Prague, Czech Republic; *Vancouver, Canada)

293 • EFFECT OF METFORMIN ON INSULIN RESISTANCE, GLUCOSE AND LIPIDMETABOLISM AND BLOOD PRESSURE IN PATIENTS WITH MILD ARTERIALHYPERTENSION AND METABOLIC SYNDROMED. Duishvili, V. Mychka, I. Chazova (Moscow, Russia)

294 • METABOLIC SYNDROME AMPLIFIES HYPERTENSION-RELATED TARGETORGAN DAMAGEG. Mulè, E. Nardi, S. Cottone, P. Cusimano, A. Palermo, V. Volpe, G. Piazza, G. Mezzatesta, G. Andronico, G. Cerasola (Palermo, Italy)

295 • DIFFERENTIAL EFFECT OF VALSARTAN AND ATENOLOL ON TRIGLYCERIDESAND INSULIN RESISTANCE IN OBESE HYPERTENSIVE PATIENTSJ. Jordan, A.M. Sharma*, J. Scholze, G. Weidinger**, U. Kreuzberg** (Berlin,Germany; *Hamilton, Canada; **Nuremberg, Germany)

296 • WHICH COMPONENTS OF THE METABOLIC SYNDROME ARE ASSOCIATEDWITH ATHEROSCLEROSIS IN PATIENTS WITH TYPE 1 DIABETES?N. Darus, M. Bots, M. Muis, H. Bilo*, R. Hoogma**, D. Grobbee, R. Stolk (Utrecht,*Zwolle, **Gouda, The Netherlands)

297 • IRBESARTAN REDUCES ALBUMINURIA BOTH IN OBESE AND NON OBESEHYPERTENSIVE PATIENTS INDEPENDENTLY OF BLOOD PRESSURE CONTROLC. Calvo1, J. Honorato2, J. Vivanco3, P. Aranda4, J. Sobrino5, M.A. Rodriguez6, J. Franco7, J. Bromsons8, J.C. Blázquez9, M. Luque10, F. Tornero11, A. Sánchez12,J.L. Asín13, J.J. Unzue13, F. de Alvaro14 (1Santiago de Compostela, 2Pamplona,3Guipuzcoa, 4Malaga, 5Barcelona, 6Almeria, 7Motril, 8Gerona, 9Alicante, 10Madrid,11Cuenca, 12Salamanca, 13Pamplona, 14Madrid, Spain)

298 • IMPROVEMENT OF INSULIN RESISTANCE AND MICROALBUMINURIA INPATIENTS WITH ESSENTIAL HYPERTENSION BY ANGIOTENSIN II RECEPTORBLOCKERS. Watanabe, T. Okura, K. Murakami*, M. Kurata, J. Irita, S. Manabe, K. Miyoshi, T. Fukuoka, J. Higaki (Toon, *Matsuyama, Japan)

299 • DISLYPIDEMIA,INSULIN, AND HOMOCYSTEINE IN HYPERTENSIVE PATIENTSWITH OBSTRUCTIVE SLEEP APNEAN. Zvartau, Yu. Sviryaev, T. Ivanova, O. Rotari, M. Sushina, A. Kalinkina*, A. Conrady(St. Petersburg, *Moscow, Russia)


Metabolic Syndrome andObesityPoster Session 9


300 • INFLUENCE OF METABOLIC STATUS ON THE REACTIVITY AND RECOVERYOF BLOOD PRESSURE IN NORMOTENSIVES AND UNTREATED HYPERTENSIVESR. Seibt, J. Hardt, K. Scheuch (Dresden, Germany)

301 • REGULAR AEROBIC EXERCISE CAN REDUCE ARTERIAL STIFFNESS INOBESE HYPERTENSIVE PATIENTSS. Sha, M. Igaki, N. Sano, Y. Yamazaki, M. Nishioka (Toyo-oka, Japan)

302 • BLOCKADE OF SYMPATHETIC NERVOUS SYSTEM ACTIVITY BYRILMENIDINE INCREASES PLASMA ADIPONECTIN CONCENTRATION IN PATIENTSWITH ESSENTIAL HYPERTENSIONL. Nowak, M. Adamczak, A. Wiecek (Katowice, Poland)

303 • COMPARING LOSARTAN WITH AMLODIPINE ON REDUCING PARIETALTHICKNESS OF CAROTID ARTERIES IN A GRADE-2 HYPERTENSIVE POPULATIONM. D’Avino, A. Margarita, F. Capasso, G. Caruso, M. Rizzo, D. Caruso (Naples, Italy)

304 • SERUM LIPID ALTERATIONS IN OBESE AND/OR HYPERTENSIVE SUBJECTSAT RISK FOR THE METABOLIC SYNDROMEG. Jermendy, J. Nádas, T. Hidvégi*, K. Hetyési*, L. Bíró (Budapest, *Gyor, Hungary)

305 • IMPLICATIONS OF hs-CRP AND METABOLIC SYNDROME IN STATINTREATMENT STRATEGY IN HYPERTENSIVE PATIENTSJ.M. Pascual, A. Gomez-Belda, E. Rodilla, J.A. Costa, M. Arago, A. Miralles, C. Gonzalez (Sagunto, Spain)

306 • LEUKOCYTE COUNT AND GLOBULAR SEDIMENTATION VELOCITY, COST-EFFECTIVE MARKERS OF INFLAMMATION, ARE INCREASED IN METABOLICSYNDROMEC. Calvo, R. Hermida*, V. Lahera**, D.E. Ayala*, M. Covelo, M. Rodríguez, J.E. López(Santiago, *Vigo, **Madrid, Spain)

307 • ADMINISTRATION TIME-DEPENDENT EFFICACY OF STATINS INHYPERLIPIDEMIC PATIENTS WITH ESSENTIAL HYPERTENSIONC. Calvo, J.E. López, R. Hermida*, D.E. Ayala*, M. Covelo, M. Rodríguez, M.L. Romero, M.J. Fontao*, R. Soler*(Santiago, *Vigo, Spain)

308 • METABOLIC SYNDROME SCORE AND AMBULATORY BLOOD PRESSURE INUNTREATED ESSENTIAL HYPERTENSIONS. Meani, C. Cuspidi, C. Valerio, E. Catini, V. Fusi, C. Sala, A. Zanchetti (Milan, Italy)

309 • HAEMODYNAMIC AND RESPIRATORY CONSEQUENCES OF BEINGOVERWEIGHT IN SLEEP APNEA SYNDROMEJ.P. Baguet, J.L. Pepin, L. Hammer, P. Levy, H. Pierre, J.M. Mallion (Grenoble, France)

310 • NOCTURNAL O2 SATURATION IS LOWER IN APNEIC PATIENTS WITHMETABOLIC SYNDROMEJ.P. Baguet, J.L. Pepin, L. Hammer, P. Levy, H. Pierre, J.M. Mallion (Grenoble, France)

311 • LONG-TERM ANTIHYPERTENSIVE MONOTHERAPY WITH RILMENIDINEDOES NOT INFLUENCE THE BODY FAT CONTENT AND PLASMA LEPTINCONCENTRATION IN PATIENTS WITH ESSENTIAL HYPERTENSIONM. Adamczak, L. Nowak, A. Wiecek (Katowice, Poland)

312 • ARTERIAL STIFFNESS, URINARY ALBUMIN EXCRETION AND VASCULARINFLAMMATION IN SUBJECTS WITH METABOLIC SYNDROMES. Sha, S. Tanaka, T. Miki, T. Yasumoto (Toyo-oka, Japan)

313 • HEALTHY OFFSPRING OF PATIENTS WITH METABOLIC SYNDROME HAVEUNFAVOURABLY AFFECTED THEIR RISK PROFILET. Makris, I. Paizis, P. Krespi, D. Papadopoulos, A. Zilidis, S. Vichos, A. Hatzizacharias,V. Votteas (Athens, Greece)


314 • CHARACTERISTICS OF METABOLIC SYNDROME IN PATIENTS WITH WEIGHTEXCESS: DIFFERENCES BETWEEN WHO AND ATP III CRITERIAP. Rodriguez, A. Delucchi, O. Volpe* (Buenos Aires, *Mar del Plata, Argentina)

315 • INTERRELATION BETWEEN MACRORHEOLOGICAL VARIABLES AND INSULINRESISTANCE IN METABOLIC SYNDROMER. Lo Presti, M. Montana, D. Sinagra, A.M. Scarpitta, A. Catania, G. Caimi (Palermo,Italy)

316 • INSULIN RESISTANCE AND POLYMORPHONUCLEAR LEUKOCYTEMEMBRANE FLUIDITY IN OBESE SUBJECTS WITH AND WITHOUT TYPE 2DIABETES MELLITUSR. Lo Presti, D. Sinagra, B. Canino, M. Montana, A.M. Scarpitta, G. Caimi (Palermo,Italy)

317 • UPPER BODY OBESITY AND ALTERED DIPPING STATUS IN HYPERTENSIOND. Raev (Sofia, Bulgaria)

318 • EPIDEMIOLOGY OF ABDOMINAL OBESITY IN A SPANISH HYPERTENSIVEPOPULATIONJ. Bonet, R. Romero, A. De la Sierra*, M. Perez*, J.S. Lopez*, M.T. Antonio*, M.T. Aguilera*, J.M. Taboada* (Badalona, *Barcelona, Spain)

319 • PREVALENCE AND CLINICAL FEATURES OF METABOLIC SYNDROME IN THESPANISH HYPERTENSIVE POPULATIONA. De la Sierra, R. Romero*, J. Bonet*, M. Perez, J.S. Lopez, M.T. Antonio, M.T. Aguilera, J.M. Taboada (Barcelona, *Badalona, Spain)

320 • PREVALENCE AND CLINICAL CHARACTERISTICS OF OBESITY IN A SPANISH HYPERTENSIVE POPULATIONR. Romero, J. Bonet, A. De la Sierra*, M. Perez*, J.S. Lopez*, M.T. Antonio*, M.T. Aguilera*, J.M. Taboada* (Badalona, *Barcelona, Spain)

321 • GLUCOSE INTOLERANCE INCREASES LEFT VENTRICULAR MASS INDEX ANDARTERIAL STIFFNESS IN MILD HYPERTENSIVESO. Paez, P. Puleio, M. De Maria, N. Prieto (Buenos Aires, Argentina)

322 • IS BAROREFLEX IMPAIRMENT A COMPONENT OF THE METABOLICSYNDROME? A SUGGESTION FROM THE LINOSA STUDYD. Lucini, A. Bellia*, S. Bucchieri**, G. Di Fede**, R. Lauro*, M. Pagani (Milan,*Rome, **Palermo, Italy)

323 • PREDICTORS OF METABOLIC SYNDROME: FINDINGS OF THE OLIVETTIPROSPECTIVE HEART STUDYF. Galletti, L. D’Elia, A. Barbato, G. Barba*, R. Iacone, O. Russo, M. Versiero, A. Siani*, F.P. Cappuccio**, P. Strazzullo (Naples,*Avellino, Italy; **London, UK)

324 • THE ROLE OF LEPTIN-TROMBOMODULIN COMPLEX IN ARTERIALHYPERTENSION AND ACCOMPANYING ISCHEMIC HEART DISEASE IN PATIENTSWITH OBESITYR. Yakymchuk, M. Orynchak (Ivano-Frankivsk, Ukraine)

325 • EFFECTS OF OLMESARTAN ON INSULIN SENSITIVITY IN NON-DIABETICHYPERTENSIVE PATIENTS WITH METABOLIC SYNDROMEF.J. Martínez-Martín, A. Macías-Batista, H. Rodríguez-Rosas, I. Peiró-Martínez, P. Soriano, P.L. de Pablos-Velasco (Las Palmas de Gran Canaria, Spain)

326 • METABOLIC PARAMETERS IN ISOLATED SYSTOLIC HYPERTENSIONJ.A. Papadakis, G. Vrentzos, I. Kazakou, E.E. Mazokopakis, S. Lazaridou,

E.S. Ganotakis (Heraklion, Greece)

327 • CONSUMPTION OF WHEAT FIBRE SIGNIFICANTLY DECREASE SYSTOLICAND DIASTOLIC BLOOD PRESSUREJ. Lavre, S. Lavre, M. Sabovic*, I. Keber* (Slovenj Gradec, *Ljubljana, Slovenia)


328 • PROSPECTIVE AND RANDOMIZED STUDY OF THE ANTIHYPERTENSIVEEFFECT OF 3 ANTIHYPERTENSIVE AGENTS, LOSARTAN, AMLODIPINE, ANDLISINOPRIL, IN HYPERTENSIVE PATIENTSS.L. Lin, S.C. Wu, C.P. Liu (Kaohsiung City, Taiwan, China)

329 • EFFECTS OF OLMESARTAN AND ANTIOXIDANT VITAMINS C AND E ONMICROINFLAMMATION AND SERUM LIPID LEVELS IN PATIENTS WITHHYPERTENSIONE. Bán, L. Máthé, I. Major (Targu Mures, Romania)

330 • RANDOMIZED, CROSSOVER STUDY TO ASSESS THE COMPARATIVE EFFECTOF VALSARTAN AND AMLODIPINE ON CARDIAC AUTONOMIC NERVOUS ACTIVITYIN HYPERTENSIVE PATIENTSA. Nakano, J.D. Lee, Y. Takeishi*, T. Hirai**, T. Kinugawa***, M. Fujita**** (Fukui,*Yamagata, **Toyama, ***Osaka, ****Kyoto, Japan)

331 • IS THERE AN INFLUENCE OF A LONG-TERM ENALAPRIL ADMINISTRATIONON THE RENAL FUNCTION OF HYPERTENSIVE PATIENTS WITH SEVERE CHRONICRENAL FAILUREL. Vernaglione (Manduria-TA, Italy)

332 • WHAT’S THE ROLE OF W-3 FATTY ACIDS IN REDUCING THECARDIOVASCULAR RISK IN PATIENTS ON LONG-TERM HEMODIALYSIS?L. Vernaglione, C. Cristofano, S. Chimienti (Manduria-TA, Italy)

333 • IMPACT OF A SHORT COURSE OF ATORVASTATIN ON RENALHAEMODYNAMICS AND PROXIES OF CARDIOVASCULAR MORBIDITY INESSENTIAL HYPERTENSIVES: PRELIMINARY DATAL. Vernaglione, C. Cristofano, S. Chimienti (Manduria-TA, Italy)

334 • OUTCOMES IN HIGH RISK HYPERTENSIVES RANDOMIZED TO CALCIUMCHANNEL BLOCKER VERSUS ANGIOTENSIN CONVERTING ENZYME INHIBITOR INTHE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEARTATTACK TRIAL (ALLHAT)F. Leenen, C. Nwachuku*, W. Cushman**, H. Black***, L. Simpson****, B. Davis****, for the ALLHAT Collaborative Research Group**** (Ottawa, Canada;*Bethesda, MD, **Memphis, TN, ***Chicago, IL, ****Houston, TX, USA)

335 • RELATIONSHIP BETWEEN MORNING BLOOD PRESSURE OR HEART RATEMORNING SURGE AND BLOOD PRESSURE OR HEART RATE VARIABILITY DURINGDAYTIMES.T. Solomou, E.S. Hamodraka, K.E. Paravolidakis, A.A. Grivas, M.P. Psilogiannopoulos, E.E. Anagnostakis, T.S. Apostolou (Athens, Greece)

336 • INFLUENCE OF THE PERINDOPRIL MONOTHERAPY AND PERINDOPRILCOMBINED WITH INDAPAMIDE ON 24-H BLOOD PRESSURE PROFILE IN PATIENTSWITH ESSENTIAL HYPERTENSIONL. Ratova, I. Chazova (Moscow, Russia)


Clinical TrialsPoster Session 10


337 • LEFT VENTRICULAR MASS INDEX AND 48-HOURS BLOOD PRESSUREMONITORING IN HEMODIALYSIS PATIENTSR. Ekart, R. Hojs, V. Kanic, S. Bevc, B. Dvorsak, B. Balon-Pecovnik (Maribor,Slovenia)

338 • EFFECT OF CALCIUM SUPPLEMENTATION ON PREVENTION OF PREGNANCYINDUCED HYPERTENSION IN IRANM. Kashanian, M. Rayka (Tehran, Iran)

339 • CALCIUM MOBILIZATION, PHOSPHATIDYLSERINE AND MICROPARTICLES INPLATELETS OF HYPERTENSIVES MEASURED BY FLOW CYTOMETRY. EFFECT OFDOXAZOSIN GITSM. Labiós, M. Martínez, F. Gabriel, V. Guiral, S. Ruiz-Aja, M.A. Hernández-Presa*,

J. Aznar (Valencia, *Madrid, Spain)

340 • EFFECTS OF DIFFERENT CLASSES OF ANTIHYPERTENSIVE AGENTS ONPULSE PRESSUREM. Anghel, M. Macri, V. Greere, E. Radu Sultanescu, A. Gutu (Bucharest, Romania)

341 • BLOOD PRESSURE NORMALIZATION WITH AMLODIPINE IN PREVIOUSLYUNCONTROLLED HYPERTENSIVE PATIENTS IN GENERAL PRACTICE IN BELGIUMP. Van der Niepen, K. Houbracken (Brussels, Belgium)

342 • IS DOPAMINE A MODULATOR OF CARDIOVASCULAR RESPONSE INHYPERTENSIVE SUBJECTS?F. Contreras, J. Rocafull, M. Carrucci, J. Cevallos, C. Fouillioux, G. Ibáñez, M. González,M. Velasco, G.A. Cabezas (Caracas, Venezuela)

343 • HEART RATE VARIABILITY AND ECG CHANGES IN 148 DANISH PATIENTSAFTER TWO YEARS IN THE VALUE TRIALO.L. Pedersen, J. Refsgaard, E.S. Nielsen (Viborg, Denmark)

344 • THE ROLE OF AMLODIPINE IN A GLOBAL CV RISK MANAGEMENTPROGRAM IN POSTMENOPAUSAL HYPERTENSIVE WOMENP. van der Niepen, C. Brohet, K. Houbracken (Brussels, Belgium)

345 • DIFFERENCES IN LEFT ATRIAL SYSTOLIC FUNCTION IN PRIMARY ANDFAMILIAL AMYLOIDOSISI. Moyssakis, D. Papadopoulos, E. Gialafos, A. Zilidis, V. Votteas, F. Triposkiadis(Athens, Greece)

346 • FIXED-DOSE VALSARTAN + HYDROCHLOROTHIAZIDE COMBINATIONTHERAPY COMPARED WITH AMLODIPINE MONOTHERAPY IN HYPERTENSIVEPATIENTS WITH ADDITIONAL CARDIOVASCULAR RISK FACTORS: THE VASTSTUDYL. Ruilope, E. Malacco*, Y. Khder**, G. Brönner***, D. Heintz** (Madrid, Spain;*Milan, Italy; **Basel, Switzerland; ***Bad Krozingen, Germany)

347 • 24-HOUR AMBULATORY BLOOD-PRESSURE EFFECTS OF VALSARTAN +HYDROCHLOROTHIAZIDE COMBINATIONS COMPARED WITH AMLODIPINE INHYPERTENSIVE PATIENTS AT INCREASED CARDIOVASCULAR RISKL. Ruilope, D. Heintz*, A. Brandao**, P. Stolt*, A. Kandra*, M. Santonastaso***, Y. Khder* (Madrid, Spain; *Basel, Switzerland; **Sao Paolo, Brazil; ***VittorioVeneto-TV, Italy)

348 • DO BULGARIAN GENERAL PRACTITIONERS KNOW THE DEFINED TARGETLEVELS FOR BLOOD PRESSURE CONTROL - RESULTS FROM BULPRAKT-HEART-STUDYB. Georgiev, N. Gotcheva, V. Baytcheva, D. Gotchev (Sofia, Bulgaria)


349 • THE FELODIPINE EVENT REDUCTION (FEVER) STUDY: A RANDOMIZEDLONG-TERM PLACEBO CONTROLLED TRIAL IN CHINESE HYPERTENSIVE PATIENTS- DESIGN AND PRINCIPAL RESULTSL. Liu, Y. Zhang, G. Liu, W. Li, X. Zhang, A. Zanchetti* (Beijing, China; *Milan, Italy)

350 • EFFICACY OF A FIRST-LINE LOW-DOSE ACEI/DIURETIC COMBINATIONTHERAPY (PRETERAX) IN STAGE II HYPERTENSIVE PATIENTSJ.J. Mourad*, B. Waeber, F. Zannad**, M. Laville***, G. Duru*, M. Andrejak**** (Lausanne, Switzerland; *Bobigny, **Nancy, ***Lyon, ****Amiens, France)

351 • GLOBAL DIFFERENCES IN BLOOD PRESSURE CONTROL, FINDINGS FROMTHE INTERNATIONAL VERAPAMIL SR-TRANDOLAPRIL STUDY (INVEST)G. Mancia, I. Zineh*, R. Cooper-DeHoff*, Q. Zhou**, A. Champion**, C. Pepine*(Milan, Italy; *Gainesville, FL, **Abbott Park, IL, USA)

352 • DIFFERING EFFECTS OF AWAKENING VERSUS BEDTIME VALSARTANADMINISTRATION ON URINARY ALBUMIN EXCRETION IN HYPERTENSIVESUBJECTSR. Hermida, C. Calvo*, D.E. Ayala, M. Covelo*, J.E. Lopez* (Vigo, *Santiago, Spain)

353 • TREATMENT OF NON-DIPPER ESSENTIAL HYPERTENSION WITH BEDTIMEADMINISTRATION OF VALSARTANR. Hermida, C. Calvo*, D.E. Ayala, M. Covelo*, M. Rodríguez*, A. Mojón, J.R. Fernández, J.E. López* (Vigo, *Santiago, Spain)

354 • ADMINISTRATION TIME-DEPENDENT EFFICACY OF VALSARTAN ONAMBULATORY BLOOD PRESSURE ACCORDING TO GENDERR. Hermida, C. Calvo*, D.E. Ayala, M. Covelo*, M. Rodríguez*, A. Mojón, J.R. Fernández, I. Alonso, J.E. López* (Vigo, *Santiago, Spain)

355 • ADMINISTRATION TIME-DEPENDENT EFFECTS OF AMLODIPINE ONAMBULATORY BLOOD PRESSURE IN PATIENTS WITH ESSENTIAL HYPERTENSIONR. Hermida, C. Calvo*, D.E. Ayala, M. Covelo*, J.E. López* (Vigo, *Santiago, Spain)

356 • VALSARTAN MONOTHERAPY EFFICIENTLY REDUCES AMBULATORY PULSEPRESSURE IN PATIENTS WITH GRADE 1-2 ESSENTIAL HYPERTENSIONR. Hermida, C. Calvo*, D.E. Ayala, M. Covelo*, M. Rodriguez*, A. Mojón, J.R. Fernández, J.E. López* (Vigo, *Santiago, Spain)

357 • EFFECTS OF NEBIVOLOL ON AMBULATORY BLOOD PRESSURE IN SMOKERAND NON-SMOKER HYPERTENSIVE PATIENTSR. Hermida, D.E. Ayala, C. Calvo*, M. Covelo*, M. Rodríguez*, M.J. Fontao, R. Soler,J.E. López* (Vigo, *Santiago, Spain)

358 • ADMINISTRATION TIME-DEPENDENT EFFECTS OF VALSARTAN ONAMBULATORY BLOOD PRESSURE IN ELDERLY HYPERTENSIVE PATIENTSC. Calvo, R. Hermida*, D.E. Ayala*, M. Covelo, M. Rodriguez, J.E. López (Santiago,*Vigo, Spain)

359 • TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND IMPAIREDGLUCOSE TOLERANCE: RESULTS FROM THE APREL STUDYI. Chazova, V. Mychka (Moscow, Russia)

360 • TELMISARTAN + HYDROCHLOROTHIAZIDE VERSUS AMLODIPINE +HYDROCHLOROTHIAZIDE IN OLDER PATIENTS WITH PREDOMINANTLY SYSTOLICHYPERTENSIONS. Neldam, for the ATHOS Group (Rodovre, Denmark)


361 • BLOOD PRESSURE AND MICROALBUMINURIA REDUCTION WITHINDAPAMIDE SR IN ELDERLY TYPE 2 DIABETIC HYPERTENSIVE PATIENTS: THENESTOR STUDYJ. Garcia-Puig1, F. Kokot2, M. Fernandez3, G. Jermendy4, L. Opie5, V. Moyseev6,A. Scheen7, C. Ionescu-Tirgoviste8, H. Saldanha9, M. Marre10 (1Madrid, Spain;2Katowice, Poland; 3Mexico, Mexico; 4Budapest, Hungary; 5Cape Town, SouthAfrica; 6Moscow, Russia; 7Liege, Belgium; 8Bucarest, Romania; 9Coimbra, Portugal;10Paris, France)

362 • THE FIXED DOSE COMBINATION OF VALSARTAN 160/HCTZ 25 INHYPERTENSIVE PATIENTS NOT CONTROLLED BY MONOTHERAPY WITHOLMESARTAN 40’ OR OLMESARTAN 20 PLUS HCTZ 12.5P. Trenkwalder, H. Samer*, R.D. Hempel**, G. Weidinger***, S. Klebs***(Starnberg, *Haag, **Berlin, ***Nuernberg, Germany)


363 • L-NAME INCREASES CEREBRAL VASCULAR MICRO-INFARCTS PRIOR TOSTROKE IN SHR: ENHANCED PROTECTION WITH LOSARTAN VERSUS ATENOLOLS. Pesant, T. Hale, A. Migneault, D. Duguay, P. Moreau, D. deBlois (Montreal,Canada)

364 • CALCITONIN GENE-RELATED PEPTIDE AND CENTRAL CONTROL OF BLOODPRESSUREM. Giuditta, A. Del Bo (Milan, Italy)

365 • DIFFERENCES IN HYPOTHALAMIC NORADRENALINE UPTAKE IN FRUCTOSE-INDUCED HYPERTENSIVE RATSA. Puyó, M. Mayer*, M. Rodríguez Fermepín, H. Peredo, B. Fernández (RamosMejía, *Buenos Aires, Argentina)

366 • DOES HYPERTENSION PREDISPOSE TO COMPLICATED CAROTID PLAQUEAND/OR CEREBRAL SYMPTOMS?J. Milei, D.R. Grana, J.C. Parodi, L. Matturri* (Buenos Aires, Argentina; *Milan,Italy)

367 • TWENTY-FOUR-HOUR PULSE PRESSURE PREDICTS LONG-TERMRECURRENCE IN ACUTE ISCHEMIC STROKE PATIENTSG. Tsivgoulis, E. Manios, K. Spengos, J. Spiliopoulou, K. Dolianitis, K. Xynos, P. Tseke, A. Dimitriou, K. Vemmos, N. Zakopoulos, M. Mavrikakis (Athens, Greece)

368 • CIRCADIAN BLOOD PRESSURE PATTERN AND COGNITIVE FUNCTION INMIDDLE-AGED ESSENTIAL HYPERTENSIVE PATIENTSC. Sierra, A. De la Sierra, M. Salamero, J. Sobrino*, M. Larrousse, M. Domenech, A. Coca (Barcelona, *Santa Coloma de Gramenet, Spain)

369 • RELATION OF LEFT VENTRICULAR HYPERTROPHY TO REGIONAL CEREBRALBLOOD FLOW-SPECT IN ESSENTIAL HYPERTENSIONC. Sierra, A. De la Sierra, F.J. Lomeña, J.C. Pare, M. Larrousse, M. Domenech, A. Coca (Barcelona, Spain)

370 • COMPARISON OF NON-INVASIVE OSCILLOMETRIC AND INTRA-ARTERIAL24-HOUR BLOOD PRESSURE MEASUREMENT IN ACUTE STROKEE. Manios, G. Tsivgoulis, K. Spengos, J. Spiliopoulou, K. Dolianitis, P. Tseke, K. Xynos, A. Dimitriou, K. Vemmos, N. Zakopoulos, M. Mavrikakis (Athens, Greece)

371 • COMPARISON OF BLOOD PRESSURE VARIABILITY BY MEANS OF NON-INVASIVE OSCILLOMETRIC AND INTRA-ARTERIAL BLOOD PRESSUREMONITORING IN ACUTE STROKE PATIENTSE. Manios, G. Tsivgoulis, K. Spengos, J. Spiliopoulou, K. Dolianitis, P. Tseke, K. Xynos, A. Dimitriou, K. Vemmos, N. Zakopoulos, M. Mavrikakis (Athens, Greece)

372 • RELATIONSHIP BETWEEN IMPAIRMENT OF BIOELECTRICAL ACTIVITY ANDSUBCLINICAL STRUCTURAL CHANGES OF THE BRAIN IN PATIENTS WITHESSENTIAL HYPERTENSIONG. Semke, V. Mordovin, S. Pekarski, N. Afanaseva, M. Kolodina (Tomsk, Russia)


BrainPoster Session 11


373 • RELATIONSHIP BETWEEN BRAIN STRUCTURAL CHANGES ANDPARAMETERS OF CLINIC AND 24H BLOOD PRESSURE IN PATIENTS WITHESSENTIAL HYPERTENSIONO. Gulkevych, E. Svyshchenko, L. Bezrodna, I. Sidorova (Kyiv, Ukraine)

374 • RELATIONSHIP BETWEEN IMPAIRMENT OF CEREBRAL BLOOD PERFUSIONAND STRUCTURAL CHANGES OF THE BRAIN AT BASELINE AND IN COURSE OFTHE TREATMENT WITH INDAPAMIDE OR ENALAPRIL IN HYPERTENSIVE PATIENTSM. Kolodina, V. Mordovin, G. Semke, S. Pekarski, T. Ripp, N. Afanaseva, P. Lukyanenok, I. Efimova (Tomsk, Russia)

375 • SILENT CEREBROVASCULAR DISEASE AND COGNITIVE FUNCTION INESSENTIAL HYPERTENSIONL. Henskens, M. van Boxtel, A. Kroon, P. Hofman, E. Gronenschild, J. Jolles, P. de Leeuw (Maastricht, The Netherlands)

376 • RELATIONSHIP BETWEEN PARAMETERS OF 24-H BLOOD PRESSURE ANDSTRUCTURAL CHANGES OF THE BRAIN IN HYPERTENSIVE PATIENTSG. Semke, V. Mordovin, S. Pekarski, N. Afanasyeva, M. Kolodina, T. Ripp (Tomsk,Russia)

377 • EVOKED VISUAL BLOOD FLOW BEFORE AND AFTER DEEP BRAINSTIMULATION IN PARKINSON’S DISEASE - A FTCD STUDYJ. Freitas, E. Azevedo, R. Santos, B. Rosengarten*, M. Carvalho (Porto, Portugal;*Essen, Germany)

378 • CEREBROVASCULAR AND CEREBRAL PERFUSION RESERVES IN PATIENTSWITH ESSENTIAL HYPERTENSIONI. Astanina, T. Ripp, I. Vorozhtsova, I. Efimova (Tomsk, Russia)

379 • HYPERTENSION, DIABETES MELLITUS AND SMOKING ON LATTERTHROMBOEMBOLIC STROKE IN GREEK POPULATIONS. Paximadas, S. Pagoni, X. Tsarouchas, G. Kalokerinos, K. Garefalakis, P. Nikitopoulou (Athens, Greece)

380 • EFFECT OF ENOXAPARIN ON BRAIN PERFUSION IN PATIENTS WITH TYPE 2DIABETES MELLITUS AND ARTERIAL HYPERTENSIONV. Mychka, I. Chazova, K. Mamyrbaeva, V. Gornostaev, V. Sergienko (Moscow,Russia)

381 • THE EFFECT OF ORAL LISINOPRIL ON BLOOD PRESSURE LEVELS IN THEACUTE AND SUB-ACUTE PHASES OF STROKED.J. Eveson, T.G. Robinson, J.F. Potter (Leicester, UK)

382 • INFLUENCE OF PERINDOPRIL MONOTHERAPY ON BLOOD PRESSURE,GLUCOSE AND LIPIDS METABOLISM AND BRAIN PERFUSION IN PATIENTS WITHMETABOLIC SYNDROMEV. Gornostaev, V. Mychka, V. Sergienko, I. Chazova (Moscow, Russia)

383 • HOMOCYSTEINE IN HYPERTENSIVES WITH AN INCREASED MEDIUM-INTIMACAROTID THICKNESS: IS IT A RISK FACTOR AND A MARKER FOR CEREBRAL-VASCULAR DISEASES?M. D’Avino, E. De Simone, E. Laurella, N. Bevilacqua, G. Caruso, F. Capasso, D. Caruso (Naples, Italy)

384 • PROGNOSTIC VALUE OF AMBULATORY BLOOD-PRESSURE RECORDINGS INSTROKE SURVIVORS WITH TREATED HYPERTENSIONG. Tsivgoulis, E. Manios, K. Spengos, J. Spiliopoulou, K. Dolianitis, K. Xynos, P. Tseke, A. Dimitriou, K. Vemmos, N. Zakopoulos, M. Mavrikakis (Athens, Greece)


14.00-15.00 ESH Business Meeting



15.30-16.30 Onset of a systolic hypertension in a 64 yearsold treated woman

X. Girerd (Paris, France)


Clinical Case


Chairmen: R. Asmar (Paris, France)H.A.J. Struijker-Boudier (Maastricht, The Netherlands)

15.30 • LECTURE: “CLINICAL PROGNOSTIC VALUE OF CARDIOVASCULAR REMODELLING INHYPERTENSION”E. Agabiti Rosei (Brescia, Italy)

16.00 • STIFFNESS OF CAPACITIVE AND CONDUIT ARTERIES: PROGNOSTIC SIGNIFICANCE FOR HIGH RISK PATIENTSA. Guerin, B. Pannier, G. London (Fleury-Mérogis, France)

16.15 • LONGITUDINAL MOVEMENTS AND THE RESULTING SHEAR STRAIN OFTHE ARTERIAL WALL - AN OVERLOOKED PHENOMENON WITH IMPORTANTIMPLICATIONS FOR VASCULAR HEMODYNAMICS AND BIOLOGYM. Cinthio, Å. Rydén Ahlgren*, J. Bergkvist, T. Jansson, H.W. Persson, K. Lindström(Lund, *Malmö, Sweden)

16.30 • RAMIPRIL REDUCES LARGE ARTERY STIFFNESS IN PERIPHERALARTERIAL DISEASE AND PROMOTES ELASTOGENIC REMODELLING IN HUMANSMOOTH MUSCLE CELL CULTUREA.A. Ahimastos, A.K. Natoli, A. Lawler, P.A. Blombery, B.A. Kingwell (Melbourne,Australia)

16.45 • IMPAIRED VASCULAR GROWTH IN LATE ADOLESCENCE AFTERINTRAUTERINE GROWTH RESTRICTIONJ. Brodszki, T. Länne*, D. Ley, K. Marsál (Lund, *Linköping, Sweden)


Blood VesselsOral Session 3A


Chairmen: P.W. de Leeuw (Maastricht, The Netherlands)J.A. Staessen (Leuven, Belgium)

15.30 • EFFECTS OF VALSARTAN COMPARED TO AMLODIPINE ON PREVENTINGTYPE 2 DIABETES IN HIGH RISK HYPERTENSIVE PATIENTS. THE VALUE TRIALS.E. Kjeldsen1, S. Julius2, T. Hua3, G. Mancia4, P. Larochelle5, M.A. Weber6, A. Coca7, X. Girerd8, I. Graham9, K. Jamerson2, T. McDonald10, G.T. McInnes11, R. Schmieder12, R. Viskoper13, J. Widimski14 (1Oslo, Norway; 2Ann Arbor, MI,3East Hanover, USA; 4Milan, Italy; 5Montreal, Canada; 6Brooklyn, NY, USA;7Barcelona, Spain; 8Paris, France; 9Dublin, Ireland; 10Dundee, 11Glasgow, UK;12Nürnberg, Germany; 13Ashkelon, Israel; 14Prague, Czech Republic)

15.45 • RELATION OF CARDIOVASCULAR EVENTS TO CAROTID INTIMA-MEDIATHICKNESS AND PLAQUES IN THE EUROPEAN LACIDIPINE STUDY ONATHEROSCLEROSIS (ELSA)A. Zanchetti, M. Hennig*, R. Hollweck*, G. Bond**, R. Tang**, G. Mancia (Milan,Italy; *Munich, Germany; **Winston-Salem, NC, USA)

16.00 • RELATIONSHIP BETWEEN ON-TREATMENT DIASTOLIC BLOOD PRESSUREAND PROGNOSIS IN ISOLATED SYSTOLIC HYPERTENSIONR. Fagard, L. Thijs, H. Celis, J. Staessen (Leuven, Belgium)

16.15 • ACE INHIBITION AND ENDOTHELIAL FUNCTION: THE PERFECT STUDY,SUB STUDY OF THE EUROPA TRIAL: MAIN FINDINGSM. Bots, W. Remme*, T. Lüscher**, M. Simoons*, M. Betrand°, K. Fox°°, R. Ferrari°°°, D. Grobbee (Utrecht, *Rotterdam, The Netherlands; **Zurich,Switzerland; °Lille, France; °°London, UK, °°°Brescia, Italy)

16.30 • EFFECT OF LONG-ACTING NIFEDIPINE ON BLOOD PRESSURE CONTROLAND CLINICAL OUTCOME IN PATIENTS WITH STABLE ANGINA: THE ACTIONSTUDYP.A. Poole-Wilson, J. Lubsen*, B.A. Kirwan*, S. de Brouwer (ACTION Investigators)* (London, UK; *Nyon, Switzerland)

16.45 • CARDIOVASCULAR OUTCOMES IN HYPERTENSIVES WITH CORONARYARTERY DISEASE RANDOMIZED TO AMLODIPINE VERSUS LISINOPRIL IN THEANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEARTATTACK TRIAL (ALLHAT)F. Leenen, C. Nwachuku*, W. Cushman**, H. Black***, L. Simpson, B. Davis, for theALLHAT Collaborative Research Group**** (Ottawa, Canada; *Bethesda, MD,**Memphis, TN, ***Chicago, IL, ****Houston, TX, USA)

Saturday, June 18 Auditorium15.30-17.00

Clinical TrialsOral Session 3B


15.30-17.00 Joint JSH-ESH Meeting

Chairmen:T. Fujita (Tokyo, Japan)A.M. Heagerty (Manchester, UK)

Morning surge as cardiovascular risk factor inhypertensionK. Kario (Jichi, Japan)

Clinical relevance of arterial stiffeningG. London (Paris, France)

The role of renin-angiotensin-aldosterone inmetabolic syndromeT. Shimosawa (Tokyo, Japan)

The role of the natriuretic peptide system inobesity-related hypertensionA. Rappelli (Ancona, Italy)

Discussion

Saturday, June 18 Blue Hall

Topical Workshop


Chairmen: K.H. Rahn (Münster, Germany)B. Trimarco (Naples, Italy)

15.30 • C TO G SUBSTITUTION IN THE RGS2 PROMOTER INCREASESSUSCEPTIBILITY TO METABOLIC SYNDROME IN MENK. Stolarz, K. Freson, R. Aerts, E. Brand*, S.M. Brand-Herrmann**, K. Kawecka-Jaszcz***, T. Kuznetsova, L. Thijs, J. Vermylen, C. Van Geet, J.A. Staessen (Leuven, Belgium; *Berlin, **Munster, Germany; ***Cracow, Poland)

15.45 • IDENTIFICATION OF GENES DETERMINING THE DIET-INDUCEDMETABOLIC SYNDROME IN THE RAT: GENE-EXPRESSION PROFILINGB. Bourdon, J. Bérubé, L. Sedova*, V. Kren*, M. Pravenec*, P. Hamet, Z. Pausova(Montreal, Canada; *Prague, Czech Republic)

16.00 • MILD ESSENTIAL HYPERTENSION AND METABOLIC SYNDROME: DOES CLINICAL MANAGEMENT ACCORDING TO CURRENT GUIDELINES PROVIDE ENOUGH PROTECTION?J. Segura, C. Campo, C. Roldán, J.A. García-Donaire, L. Guerrero, L. Fernández, L.M. Ruilope (Madrid, Spain)

16.15 • NEUROADRENERGIC AND REFLEX ABNORMALITIES IN PATIENTS WITHMETABOLIC SYNDROMEG. Grassi, R. Dell’Oro, F. Quarti Trevano, A. Facchini, F. Scopelliti, G. Seravalle, G.B. Bolla, G. Mancia (Milan, Italy)

16.30 • LEPTIN ABILITY TO INCREASES ARTERIAL PRESSURE IS PRESERVED INOBESITYK. Rahmouni, G.M. Morgan, D.A. Morgan, A.L. Mark, W.G. Haynes (Iowa City, IA,USA)

16.45 • ASSOCIATION OF INSULIN RESISTANCE, ABNORMALITIES IN TUMORNECROSIS FACTOR NETWORK AND TNF RECEPTOR 2 GENE POLYMORPHISMWITH ESSENTIAL HYPERTENSIONT. Eguchi, Y. Ohno*, T. Maruyama**, K. Hirao, T. Morii, H. Hirose, M. Hayashi, H. Kawabe, I. Saito, T. Saruta (Shinjuku-ku, *Yashio-shi, **Minato-ku, Japan)


Metabolic SyndromeOral Session 3C


Chairmen:M.H. Alderman (New York, NY, USA)G. Mancia (Milan, Italy)

17.00-17.30 Lennart Hansson Memorial LectureHeart failure, hypertension andantihypertensive treatmentP. Omvik (Bergen, Norway)

17.30-18.20 Debate on:Surrogate markers in hypertension

ProL.M. Ruilope (Madrid, Spain)

ConB. Williams (Leicester, UK)


Plenary Session

Documents

Saturday, June 18 Breakfast Workshop Red Hall 1 ... · G.A. van Montfrans (Amsterdam, The Netherlands) Deep relaxation needed for shallow drop in blood pressure. Overview of clinical